AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC. furp.org, nonprofit organization profile, tax years 2011–2024. https://furp.org/org/augusta-university-research-institute-inc-581418202. Retrieved 2026-11-22.
APA furp.org. (n.d.). AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC [Nonprofit organization profile; tax years 2011–2024]. Retrieved November 22, 2026, from https://furp.org/org/augusta-university-research-institute-inc-581418202
MLA “AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC.” furp.org, tax years 2011–2024, https://furp.org/org/augusta-university-research-institute-inc-581418202. Accessed 22 Nov. 2026.
Retrieved 2026-11-22; covers tax years 2011–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
Related institution: Augusta University Exact (research)
2024 · Form 990 · revenue $105.9M ($108.7M in 2025 dollars) · expenses $103.1M · assets $29.5M
- Also known as
- INC
- EIN
- 58-1418202
- Address
- 1120 15TH ST, AUGUSTA, GA 30912-0004
- Website
- WWW.AUGUSTA.EDU/RESEARCH/EXPLORE/SPA/ABOUT-AURI.P
- NTEE code
- B50 Graduate, Professional Schools (Separate Entities) (Education) published (IRS Business Master File, as B500)
- FURP topic
- science: research education · women: issues (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- April 1981 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (THE "INSTITUTE") WAS INCORPORATED UNDER THE LAWS OF THE STATE OF GEORGIA AS A NONPROFIT CORPORATION ON JULY 31, 1980. THE INSTITUTE QUALIFIED AS A TAX-EXEMPT CORPORATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE PURPOSE OF THE INSTITUTE IS TO SERVE AUGUSTA UNIVERSITY (THE "UNIVERSITY") AND ENHANCE ITS EXCELLENCE AS A RESEARCH INSTITUTION. THE INSTITUTE CONTRIBUTES TO THE RESEARCH FUNCTION OF THE UNIVERSITY BY SECURING GIFTS, CONTRIBUTIONS, AND GRANTS FROM OBTAINING CONTRACTS WITH SUCH INDIVIDUALS OR ENTITIES FOR THE PERFORMANCE OF SPONSORED RESEARCH, DEVELOPMENT, OR OTHER PROGRAMS IN THE VARIOUS UNIVERSITY SCHOOLS, DEPARTMENTS, AND OTHER UNITS WITHIN THE AU ENTERPRISE.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
50 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Dr Brooks Keel Chair | PRESIDENT, EX-OFFICIO | 2016-2024 | $747,501 | $8,807,499 | 1 |
| Dr Neil Mackinnon | EXEC VICE PRES & PROVOST | 2021-2024 | $386,965 | $1,809,907 | 3 |
| Dr Michael Diamond | VICE CHAIR - VOTING | 2014-2024 | $504,760 | $1,557,300 | 3 |
| Dr Jorge Cortes | SECRETARY - VOTING | 2023-2024 | $776,083 | $1,486,862 | 1 |
| Jennifer Sullivan Phd | INTERIM PROVOST - VOTING | 2018-2024 | $404,423 | $804,768 | 2 |
| Mr Jason Guilbeault | AVP, SPONSORED PROGRAM ADMINISTRATION | 2022-2024 | $237,835 | $726,510 | 1 |
| Dr Rudolf Lucas | PROFESSOR | 2021-2024 | $180,949 | $695,945 | 1 |
| Russell Keen | CHAIRMAN - VOTING | 2024 | $618,135 | $618,135 | 12 |
| Yvonne Turner | TREASURER - VOTING | 2024 | $591,729 | $591,729 | 4 |
| Dr Lynn Hedrick | CO-DIREC., MCG-IMMUNOLOGY CTR - VOTING | 2024 | $448,653 | $448,653 | 1 |
| Dr Andrew Balas | PROFESSOR - VOTING | 2023-2024 | $198,439 | $400,201 | 2 |
| Dr Dustin Avent-Holt | PROFESSOR - VOTING | 2022-2024 | $163,406 | $396,942 | 1 |
| Dr Lori Bolgla | PROFESSOR - VOTING | 2023-2024 | $141,121 | $273,556 | 1 |
| Dr Chris Mckinney | INT EXECUTIVE DIRECTOR, NON-VOTING | 2024 | $252,762 | $252,762 | 2 |
| Ms Cheyanna Mitchell | INTERIM AVP, SPONSORED PROGRAM ADMIN - NON-VOTING | 2024 | $196,031 | $196,031 | 1 |
| David Hess Md (former) | DEAN - NON VOTING | 2011-2018 | $607,334 | $3,144,926 | 4 |
| Dr Michael Diamond Vice (former) | CHAIR, SVPR, EX-OFFICIO VO | 2018-2022 | $497,935 | $2,443,394 | 1 |
| Ricardo Azziz MD (former) | CHAIR - VOTING MEMBER | 2011-2014 | $707,557 | $2,126,345 | 10 |
| Gretchen Caughman (former) | TREAS., EXEC VP & PROVOST, VOTING | 2011-2019 | $395,261 | $1,819,191 | 4 |
| Dr Michael P Diamond Vice (former) | CHAIR, SVPR - EX-OFFICIO VOTING | 2016-2017 | $615,907 | $1,220,583 | 1 |
| Dr Betty Pace (former) | INTERIM SECTION CHIEF, VOTING | 2018-2020 | $347,523 | $1,042,683 | 1 |
| Dr David Mattson (former) | FORMER VOTING MEMBER | 2021-2023 | $351,077 | $1,023,821 | 1 |
| Dr David Fulton (former) | SECRETARY, DIRECTOR, VOTING | 2017-2019 | $317,965 | $916,518 | 1 |
| Dr Gretchen Caughman Evp (former) | PROVOST - EX-OFFICIO VOTING | 2016-2017 | $382,386 | $761,274 | 1 |
| Diego Vazquez (former) | EXECUTIVE DIRECTOR, NON-VOTING | 2018-2020 | $226,266 | $652,986 | 1 |
| Dr Raghavan Raju (former) | PROFESSOR, VOTING | 2017-2019 | $220,098 | $618,776 | 1 |
| Dr Manuela Bartoli (former) | FORMER VOTING MEMBER | 2021-2023 | $216,728 | $610,746 | 1 |
| Dr Nita Maihle (former) | PROFESSOR - NON-VOTING | 2017-2018 | $268,859 | $579,889 | 1 |
| Dr Wendy Bollag (former) | FORMER VOTING MEMBER | 2016-2023 | $148,827 | $554,201 | 1 |
| Mark Hamrick (former) | SR VICE PRES - VOTING MEMBER | 2011-2013 | $308,506 | $534,752 | 2 |
| Dr Trinanjan Datta (former) | ASSOCIATE PROFESSOR, VOTING | 2018-2021 | $116,058 | $452,796 | 1 |
| Sarah White (former) | ASSOC VP NON-VOTING M | 2013-2014 | $213,657 | $427,918 | 1 |
| Dr Gretchen Caughman - 63020 (former) | TREAS., EXEC VP & PROVOST (RETIRED) | 2020 | $358,011 | $358,011 | 1 |
| Sarah Whiteexec Dirresigned (former) | AVP RESEARCH EX-OFFICIO NONVOTING | 2016-2017 | $138,299 | $346,880 | 1 |
| Dr Elizabeth G Nesmith (former) | ASSOC PROFESSOR | 2011-2014 | $121,775 | $333,523 | 1 |
| David Mattson 0720- (former) | DEP. CHAIR, VOTING | 2020 | $326,998 | $326,998 | 1 |
| Dr David Fulton 63020 (former) | SECRETARY, DIRECTOR(FORMER) | 2020 | $325,957 | $325,957 | 1 |
| William Rainey (former) | VOTING MEMBER | 2011 | $255,081 | $255,081 | 1 |
| Jennifer Sullivan -63020 (former) | PROFESSOR (FORMER) | 2020 | $239,551 | $239,551 | 1 |
| Raghavan Raju 63020 (former) | PROFESSOR (FORMER) | 2020 | $218,541 | $218,541 | 1 |
| Betty Aldridge (former) | EX DIRECTOR | 2011 | $204,112 | $204,112 | 1 |
| Jason Guilbeault 422-622 (former) | EXEC.DIR. - NON VOTING | 2021 | $196,932 | $196,932 | 1 |
| Dr Manuela Bartoli 0720- (former) | PROFESSOR, VOTING | 2020 | $193,094 | $193,094 | 1 |
| Sheree Wright721-322 (former) | EXEC.DIR. - NON VOTING | 2021 | $189,591 | $189,591 | 1 |
| Dr Anatolij Horuzsko-Professor (former) | TERM EXPIRED 06/30/2017 | 2017 | $169,189 | $169,189 | 1 |
| Dr anatolij horuzsko (former) | Professor - voting member | 2016 | $159,951 | $159,951 | 1 |
| Dr Wendy Bollag 0720- (former) | PROFESSOR, VOTING | 2020 | $132,498 | $132,498 | 1 |
| Dr Wendy Bollag - Professor (former) | TERM EXPIRED 06/30/2017 | 2017 | $132,149 | $132,149 | 1 |
| Dr Trinanjan Datta Associate (former) | PROFESSOR - VOTING | 2017 | $98,771 | $98,771 | 1 |
| Betty Aldridgeretired-20118 (former) | VP RES ADM - NON VOTING | 2017 | $77,859 | $77,859 | 1 |
Officers and directors, no compensation reported
13 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Drrick Richards (former) | CHAIRMAN, VOTING | 2023 | 1 | $0 reported | 1 |
| Dr John Richards Jr (former) | CHAIR AUDIT & FIN. COMM., | 2018-2022 | 1 | $0 reported | 1 |
| Dr Zach Kelehear 720-1220 (former) | TREAS., EX-OFFICIO | 2020 | 1 | $0 reported | 1 |
| Neil Mackinnon121- (former) | TREAS., VOTING | 2020 | 1 | $0 reported | 1 |
| Dr Lois Ellison (former) | TREASURER (DECEASED 4/20/19) | 2011-2018 | 1 | $0 reported | 1 |
| Dr John W Richards Jr Chair (former) | AUDIT AND FIN COMM, VOTING | 2017 | 1 | $0 reported | 1 |
| Diego Vazquez - 020118 (former) | EXECUTIVE DIRECTOR - NON VOTING | 2017 | 1 | $0 reported | 1 |
| Dr john w Richards chair (former) | audit and fin comm., voting | 2016 | 1 | $0 reported | 1 |
| Dr Stephen Black (former) | SENATE APPOINTED - VOTING | 2011-2014 | 5 | $0 reported | 1 |
| Dr John R Richards (former) | CHAIR - FIN. COMMITTEE (VOTING) | 2014 | 5 | $0 reported | 1 |
| Dr Jennifer Pollock (former) | SENATE APPOINTED - VOTING | 2011-2013 | 5 | $0 reported | 1 |
| William Thompson (former) | VOTING MEMBER (RESIGNED DE | 2013 | 5 | $0 reported | 1 |
| Julian Osbon (former) | VOTING MEMBER | 2011 | 5 | $0 reported | 1 |
People by year
2024 · 15 people listed · 15 paid, $5.8M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR JORGE CORTES | SECRETARY - VOTING | 1 | $0 | $724,024 | $52,059 | $776,083 | 1 |
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO | 1 | $0 | $555,467 | $192,034 | $747,501 | 1 |
| DR RUSSELL KEEN | CHAIRMAN - VOTING | 1 | $0 | $509,183 | $108,952 | $618,135 | 12 |
| MS YVONNE TURNER | TREASURER - VOTING | 1 | $0 | $451,328 | $140,401 | $591,729 | 4 |
| DR MICHAEL DIAMOND | VICE CHAIR - VOTING | 1 | $0 | $458,774 | $45,986 | $504,760 | 3 |
| DR LYNN HEDRICK | CO-DIREC., MCG-IMMUNOLOGY CTR - VOTING | 1 | $0 | $404,588 | $44,065 | $448,653 | 1 |
| DR JENNIFER SULLIVAN | INTERIM PROVOST - VOTING | 1 | $0 | $318,377 | $86,046 | $404,423 | 2 |
| DR NEIL MACKINNON | EXEC VICE PRES & PROVOST | 1 | $0 | $323,826 | $63,139 | $386,965 | 3 |
| DR CHRIS MCKINNEY | INT EXECUTIVE DIRECTOR, NON-VOTING | 1 | $0 | $212,004 | $40,758 | $252,762 | 2 |
| MR JASON GUILBEAULT | AVP, SPONSORED PROGRAM ADMINISTRATION | 1 | $0 | $194,091 | $43,744 | $237,835 | 1 |
| DR ANDREW BALAS | PROFESSOR - VOTING | 1 | $0 | $174,897 | $23,542 | $198,439 | 2 |
| MS CHEYANNA MITCHELL | INTERIM AVP, SPONSORED PROGRAM ADMIN - NON-VOTING | 1 | $0 | $151,319 | $44,712 | $196,031 | 1 |
| DR RUDOLF LUCAS | PROFESSOR | 1 | $0 | $146,492 | $34,457 | $180,949 | 1 |
| DR DUSTIN AVENT-HOLT | PROFESSOR - VOTING | 1 | $0 | $116,799 | $46,607 | $163,406 | 1 |
| DR LORI BOLGLA | PROFESSOR - VOTING | 1 | $0 | $122,753 | $18,368 | $141,121 | 1 |
2023 · 13 people listed · 12 paid, $4.5M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO VOTING | 1 | $0 | $903,698 | $343,958 | $1,247,656 | 1 |
| DR JORGE CORTES | SECRETARY, VOTING | 1 | $0 | $662,166 | $48,613 | $710,779 | 1 |
| DR MICHAEL DIAMOND | VICE CHAIR, EX-OFFICIO VOTING | 1 | $0 | $457,511 | $43,208 | $500,719 | 3 |
| DR NEIL MACKINNON | TREASURER, EX-OFFICIO, VOTING | 1 | $0 | $409,646 | $80,524 | $490,170 | 3 |
| DR DAVID MATTSON | FORMER VOTING MEMBER | 1 | $0 | $309,337 | $41,740 | $351,077 | 1 |
| MR JASON GUILBEAULT | EX-OFFICIO - NON VOTING | 1 | $0 | $200,559 | $52,110 | $252,669 | 1 |
| DR MANUELA BARTOLI | FORMER VOTING MEMBER | 1 | $0 | $187,464 | $29,264 | $216,728 | 1 |
| DR ANDREW BALAS | PROFESSOR, VOTING | 1 | $0 | $179,150 | $22,612 | $201,762 | 2 |
| DR RUDOLF LUCAS | PROFESSOR, VOTING | 1 | $0 | $141,253 | $32,166 | $173,419 | 1 |
| DR WENDY BOLLAG | FORMER VOTING MEMBER | 1 | $0 | $136,054 | $12,773 | $148,827 | 1 |
| DR LORI BOLGLA | PROFESSOR - VOTING | 1 | $0 | $115,580 | $16,855 | $132,435 | 1 |
| DR DUSTIN AVENT-HOLT | PROFESSOR, VOTING | 1 | $0 | $73,611 | $35,198 | $108,809 | 1 |
| DRRICK RICHARDS | CHAIRMAN, VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
2022 · 10 people listed · 9 paid, $3.4M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO VOTI | 1 | $0 | $903,523 | $340,674 | $1,244,197 | 1 |
| DR MICHAEL DIAMOND VICE | CHAIR, SVPR, EX-OFFICIO VO | 1 | $0 | $458,011 | $39,924 | $497,935 | 1 |
| DR NEIL MACKINNON | TREAS., VOTING | 1 | $0 | $384,888 | $77,486 | $462,374 | 3 |
| DR DAVID MATTSON | DEP. CHAIR, VOTING | 1 | $0 | $304,942 | $40,559 | $345,501 | 1 |
| MR JASON GUILBEAULT | EX-OFFICIO - NON VOTING | 1 | $0 | $187,971 | $48,035 | $236,006 | 1 |
| DR MANUELA BARTOLI | PROFESSOR, VOTING | 1 | $0 | $172,965 | $28,055 | $201,020 | 1 |
| DR RUDOLF LUCAS | PROFESSOR, VOTING | 1 | $0 | $142,206 | $30,527 | $172,733 | 1 |
| DR WENDY BOLLAG | PROFESSOR, VOTING | 1 | $0 | $131,179 | $12,155 | $143,334 | 1 |
| DR DUSTIN AVENT-HOLT | PROFESSOR, VOTING | 1 | $0 | $88,563 | $36,164 | $124,727 | 1 |
| DR JOHN RICHARDS JR | CHAIR AUDIT & FIN. COMM., | 1 | $0 | $0 | $0 | $0 | 1 |
2021 · 11 people listed · 10 paid, $3.4M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO VOTING | 1 | $0 | $894,605 | $188,946 | $1,083,551 | 1 |
| DR MICHAEL DIAMOND VICE | CHAIR, SVPR, EX-OFFICIO VOTING | 1 | $0 | $436,105 | $38,196 | $474,301 | 1 |
| NEIL MACKINNON | TREAS., VOTING | 1 | $0 | $381,242 | $89,156 | $470,398 | 3 |
| DAVID MATTSON | DEP. CHAIR, VOTING | 1 | $0 | $288,297 | $38,946 | $327,243 | 1 |
| JASON GUILBEAULT 422-622 | EXEC.DIR. - NON VOTING | 1 | $0 | $155,864 | $41,068 | $196,932 | 1 |
| DR MANUELA BARTOLI | PROFESSOR, VOTING | 1 | $0 | $165,610 | $27,388 | $192,998 | 1 |
| SHEREE WRIGHT721-322 | EXEC.DIR. - NON VOTING | 1 | $0 | $158,534 | $31,057 | $189,591 | 1 |
| DR RUDOLF LUCAS | PROFESSOR, VOTING | 1 | $0 | $139,079 | $29,765 | $168,844 | 1 |
| DR WENDY BOLLAG | PROFESSOR, VOTING | 1 | $0 | $120,554 | $11,433 | $131,987 | 1 |
| DR TRINANJAN DATTA | ASSOCIATE PROFESSOR, VOTING | 1 | $0 | $95,423 | $20,635 | $116,058 | 1 |
| DR JOHN RICHARDS JR | CHAIR AUDIT & FIN. COMM., | 1 | $0 | $0 | $0 | $0 | 1 |
2020 · 15 people listed · 12 paid, $3.9M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO VOTING | 1 | $0 | $896,901 | $38,601 | $935,502 | 1 |
| DR MICHAEL DIAMOND VICE | CHAIR, SVPR, EX-OFFICIO VOTING | 1 | $0 | $425,113 | $38,601 | $463,714 | 1 |
| DR GRETCHEN CAUGHMAN - 63020 | TREAS., EXEC VP & PROVOST (RETIRED) | 1 | $0 | $316,693 | $41,318 | $358,011 | 1 |
| DR BETTY PACE | INTERIM SECTION CHIEF, VOTING | 1 | $0 | $285,193 | $62,330 | $347,523 | 1 |
| DAVID MATTSON 0720- | DEP. CHAIR, VOTING | 1 | $0 | $288,397 | $38,601 | $326,998 | 1 |
| DR DAVID FULTON 63020 | SECRETARY, DIRECTOR(FORMER) | 1 | $0 | $282,393 | $43,564 | $325,957 | 1 |
| JENNIFER SULLIVAN -63020 | PROFESSOR (FORMER) | 1 | $0 | $184,787 | $54,764 | $239,551 | 1 |
| DIEGO VAZQUEZ | EXECUTIVE DIRECTOR, NON-VOTING | 1 | $0 | $191,047 | $35,219 | $226,266 | 1 |
| RAGHAVAN RAJU 63020 | PROFESSOR (FORMER) | 1 | $0 | $166,538 | $52,003 | $218,541 | 1 |
| DR MANUELA BARTOLI 0720- | PROFESSOR, VOTING | 1 | $0 | $165,610 | $27,484 | $193,094 | 1 |
| DR WENDY BOLLAG 0720- | PROFESSOR, VOTING | 1 | $0 | $121,022 | $11,476 | $132,498 | 1 |
| DR TRINANJAN DATTA | ASSOCIATE PROFESSOR, VOTING | 1 | $0 | $97,662 | $21,041 | $118,703 | 1 |
| DR ZACH KELEHEAR 720-1220 | TREAS., EX-OFFICIO | 1 | $0 | $0 | $0 | $0 | 1 |
| DR JOHN RICHARDS JR | CHAIR AUDIT & FIN. COMM., VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
| NEIL MACKINNON121- | TREAS., VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 10 people listed · 9 paid, $3.2M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT, EX-OFFICIO VOTING | 1 | $0 | $886,819 | $37,515 | $924,334 | 1 |
| DR MICHAEL DIAMOND VICE | CHAIR, SVPR, EX-OFFICIO VOTING | 1 | $0 | $422,035 | $40,570 | $462,605 | 1 |
| DR GRETCHEN CAUGHMAN | TREAS., EXEC VP & PROVOST, VOTING | 1 | $0 | $350,281 | $44,980 | $395,261 | 4 |
| DR BETTY PACE | INTERIM SECTION CHIEF, VOTING | 1 | $0 | $285,779 | $63,281 | $349,060 | 1 |
| DR DAVID FULTON | SECRETARY, DIRECTOR, VOTING | 1 | $0 | $276,377 | $41,588 | $317,965 | 1 |
| DIEGO VAZQUEZ | EXECUTIVE DIRECTOR, NON-VOTING | 1 | $0 | $187,752 | $33,344 | $221,096 | 1 |
| DR RAGHAVAN RAJU | PROFESSOR, VOTING | 1 | $0 | $168,540 | $51,558 | $220,098 | 1 |
| DR JENNIFER SULLIVAN | PROFESSOR, VOTING | 1 | $0 | $166,822 | $51,060 | $217,882 | 2 |
| DR TRINANJAN DATTA | ASSOCIATE PROFESSOR, VOTING | 1 | $0 | $90,563 | $19,463 | $110,026 | 1 |
| DR JOHN RICHARDS JR | CHAIR AUDIT & FIN. COMM., VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 13 people listed · 11 paid, $4.1M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT - EX-OFFICIO VOTING | 1 | $0 | $894,756 | $36,781 | $931,537 | 1 |
| DR DAVID HESS | DEAN - NON VOTING | 1 | $0 | $567,309 | $40,025 | $607,334 | 4 |
| DR MICHAEL DIAMOND VICE | CHAIR, SVPR - EX-OFFICIO VOTING | 1 | $0 | $504,064 | $40,775 | $544,839 | 1 |
| DR GRETCHEN CAUGHMAN | EVP & PROVOST - EX-OFFICIO VOTING | 1 | $0 | $347,021 | $44,377 | $391,398 | 4 |
| DR BETTY PACE | INTERIM SECTION CHIEF - VOTING | 1 | $0 | $289,410 | $56,690 | $346,100 | 1 |
| DR DAVID FULTON | SECRETARY - VOTING | 1 | $0 | $266,273 | $40,543 | $306,816 | 1 |
| DR NITA MAIHLE | PROFESSOR - NON-VOTING | 1 | $0 | $219,524 | $49,335 | $268,859 | 1 |
| DR RAGHAVAN RAJU | PROFESSOR - VOTING | 1 | $0 | $164,509 | $47,041 | $211,550 | 1 |
| DIEGO VAZQUEZ | EXECUTIVE DIRECTOR - NON-VOTING | 1 | $0 | $175,188 | $30,436 | $205,624 | 1 |
| DR JENNIFER SULLIVAN | PROFESSOR - VOTING | 1 | $0 | $139,930 | $42,533 | $182,463 | 2 |
| DR TRINANJAN DATTA | ASSOCIATE PROFESSOR - VOTING | 1 | $0 | $88,975 | $19,034 | $108,009 | 1 |
| DR LOIS ELLISON | TREASURER (DECEASED 4/20/19) | 1 | $0 | $0 | $0 | $0 | 1 |
| DR JOHN RICHARDS JR | CHAIR AUDIT & FIN. COMM., VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 15 people listed · 12 paid, $3.9M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR BROOKS KEEL CHAIR | PRESIDENT - EX-OFFICIO VOTING | 1 | $0 | $822,664 | $30,869 | $853,533 | 1 |
| DR MICHAEL P DIAMOND VICE | CHAIR, SVPR - EX-OFFICIO VOTING | 1 | $0 | $583,094 | $32,813 | $615,907 | 1 |
| DR DAVID C HESS | DEAN - VOTING | 1 | $0 | $571,629 | $32,063 | $603,692 | 4 |
| DR GRETCHEN CAUGHMAN EVP | PROVOST - EX-OFFICIO VOTING | 1 | $0 | $343,783 | $38,603 | $382,386 | 1 |
| DR NITA MAIHLE | PROFESSOR - VOTING | 1 | $0 | $264,678 | $46,352 | $311,030 | 1 |
| DR DAVID FULTON | SECRETARY - VOTING | 1 | $0 | $258,941 | $32,796 | $291,737 | 1 |
| DR RAGHAVAN RAJU | PROFESSOR - VOTING | 1 | $0 | $154,583 | $32,545 | $187,128 | 1 |
| DR ANATOLIJ HORUZSKO-PROFESSOR | TERM EXPIRED 06/30/2017 | 1 | $0 | $139,861 | $29,328 | $169,189 | 1 |
| SARAH WHITEEXEC DIRRESIGNED | AVP RESEARCH EX-OFFICIO NONVOTING | 0 | $0 | $124,972 | $13,327 | $138,299 | 1 |
| DR WENDY BOLLAG - PROFESSOR | TERM EXPIRED 06/30/2017 | 1 | $0 | $120,844 | $11,305 | $132,149 | 1 |
| DR TRINANJAN DATTA ASSOCIATE | PROFESSOR - VOTING | 1 | $0 | $84,750 | $14,021 | $98,771 | 1 |
| BETTY ALDRIDGERETIRED-20118 | VP RES ADM - NON VOTING | 1 | $0 | $77,859 | $0 | $77,859 | 1 |
| DR LOIS ELLISON | TREASURER - VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
| DR JOHN W RICHARDS JR CHAIR | AUDIT AND FIN COMM, VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
| DIEGO VAZQUEZ - 020118 | EXECUTIVE DIRECTOR - NON VOTING | 1 | $0 | $0 | $0 | $0 | 1 |
2016 · 9 people listed · 7 paid, $2.8M · 0 employees · 2 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| dr brooks keel chair | President - ex-offico voting | 1 | $0 | $803,698 | $35,990 | $839,688 | 1 |
| Dr michael p Diamond vice | chair, svpr - ex-officio voting | 1 | $0 | $564,822 | $39,854 | $604,676 | 1 |
| dr DAVID C HESS | dept. chair - VOTING MEMBE | 1 | $0 | $450,687 | $44,061 | $494,748 | 4 |
| dr gretchen caughman evp | provost - ex-officio voting | 1 | $0 | $335,488 | $43,400 | $378,888 | 1 |
| sarah whiteexec dirRESIGNED | avp research ex-officio no | 24 | $0 | $181,927 | $26,654 | $208,581 | 1 |
| Dr anatolij horuzsko | Professor - voting member | 1 | $0 | $126,494 | $33,457 | $159,951 | 1 |
| Dr Wendy Bollag | Professor - voting member | 1 | $0 | $118,678 | $11,375 | $130,053 | 1 |
| DR LOIS ELLISON | TREASURER - voting member | 1 | $0 | $0 | $0 | $0 | 1 |
| Dr john w Richards chair | audit and fin comm., voting | 1 | $0 | $0 | $0 | $0 | 1 |
2014 · 9 people listed · 6 paid, $2.4M · 0 employees · 3 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DR RICARDO AZZIZ | CHAIR - VOTING MEMBER | 5 | $0 | $560,382 | $147,175 | $707,557 | 10 |
| DR MICHAEL P DIAMOND | SR VICE PRES-VOTING MEMBER | 5 | $0 | $517,646 | $34,175 | $551,821 | 3 |
| DR DAVID C HESS | VOTING MEMBER | 5 | $0 | $430,534 | $55,385 | $485,919 | 4 |
| DR GRETCHEN CAUGHMAN | VOTING MEMBER AND OFFICER | 5 | $0 | $293,026 | $60,433 | $353,459 | 4 |
| SARAH WHITE | ASSOC VP NON-VOTING M | 5 | $0 | $168,543 | $45,114 | $213,657 | 1 |
| DR ELIZABETH G NESMITH | ASSOC PROFESSOR | 5 | $0 | $107,852 | $13,923 | $121,775 | 1 |
| LOIS ELLISON | TREASURER - VOTING MEMBER | 5 | $0 | $0 | $0 | $0 | 1 |
| DR STEPHEN BLACK | SENATE APPOINTED - VOTING | 5 | $0 | $0 | $0 | $0 | 1 |
| DR JOHN R RICHARDS | CHAIR - FIN. COMMITTEE (VOTING) | 5 | $0 | $0 | $0 | $0 | 1 |
2013 · 10 people listed · 6 paid, $2.2M · 0 employees · 3 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICARDO AZZIZ | CHAIR - VOTING MEMBER | 5 | $0 | $573,645 | $146,413 | $720,058 | 10 |
| DAVID C HESS | VOTING MEMBER | 5 | $0 | $429,098 | $54,623 | $483,721 | 4 |
| DR GRETCHEN CAUGHMAN | VOTING MEMBER AND OFFICER | 5 | $0 | $298,969 | $59,965 | $358,934 | 4 |
| MARK HAMRICK | SR VICE PRES - VOTING MEMBER | 5 | $0 | $275,093 | $33,413 | $308,506 | 2 |
| SARAH WHITE | ASSOC VP NON-VOTING M | 5 | $0 | $171,074 | $43,187 | $214,261 | 1 |
| DR ELIZABETH G NESMITH | ASSOC PROFESSOR | 5 | $0 | $98,805 | $11,906 | $110,711 | 1 |
| LOIS ELLISON | TREASURER - VOTING MEMBER | 5 | $0 | $0 | $0 | $0 | 1 |
| DR JENNIFER POLLOCK | SENATE APPOINTED - VOTING | 5 | $0 | $0 | $0 | $0 | 1 |
| DR STEPHEN BLACK | SENATE APPOINTED - VOTING | 5 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM THOMPSON | VOTING MEMBER (RESIGNED DE | 5 | $0 | $0 | $0 | $0 | 1 |
2011 · 11 people listed · 7 paid, $2.3M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| RICARDO AZZIZ | CHAIR | 40 | $0 | $555,094 | $143,636 | $698,730 | 10 |
| DAVID C HESS | VOTING MEMBER | 40 | $0 | $415,712 | $53,800 | $469,512 | 4 |
| DR GRETCHEN CAUGHMAN | VOTING MEMBER AND OFFICER | 40 | $0 | $273,943 | $46,196 | $320,139 | 4 |
| WILLIAM RAINEY | VOTING MEMBER | 40 | $0 | $206,074 | $49,007 | $255,081 | 1 |
| MARK HAMRICK | VICE-CHAIR | 40 | $0 | $198,773 | $27,473 | $226,246 | 2 |
| BETTY ALDRIDGE | EX DIRECTOR | 40 | $0 | $165,817 | $38,295 | $204,112 | 1 |
| DR ELIZABETH G NESMITH | SECRETARY & PARLIAMENTARIAN | 40 | $0 | $91,361 | $9,676 | $101,037 | 1 |
| LOIS ELLISON | TREASURER | 5 | $0 | $0 | $0 | $0 | 1 |
| DR JENNIFER POLLOCK | SENATE APPOINTED | 40 | $0 | $0 | $0 | $0 | 1 |
| JULIAN OSBON | VOTING MEMBER | 5 | $0 | $0 | $0 | $0 | 1 |
| DR STEPHEN BLACK | SENATE APPOINTED | 40 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 3 contractors · $719K
| Name | Location | Service | Paid |
|---|---|---|---|
| PABST PATENT GROUP LLC | ATLANTA, GA | LEGAL | $422,774 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $180,000 |
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $116,416 |
2023 · 3 contractors · $839K
| Name | Location | Service | Paid |
|---|---|---|---|
| PABST PATENT GROUP LLC | ATLANTA, GA | LEGAL | $472,031 |
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $186,576 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $180,000 |
2022 · 3 contractors · $679K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $389,005 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $180,000 |
| PABST PATENT GROUP LLC | ATLANTA, GA | LEGAL | $109,540 |
2021 · 2 contractors · $869K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $688,577 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $180,000 |
2020 · 2 contractors · $875K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $766,578 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $108,000 |
2019 · 2 contractors · $703K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $522,970 |
| CORNERSTONE GOVERNMENT AFFAIRS | WASHINGTON, DC | CONSULTING | $180,063 |
2018 · 2 contractors · $705K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $524,731 |
| CORNERSTONE GOVERNMENT AFFAIRS LLC | WASHINGTON, DC | CONSULTING | $180,228 |
2017 · 2 contractors · $542K
| Name | Location | Service | Paid |
|---|---|---|---|
| SMITH GAMBRELL & RUSSELL LLP | ATLANTA, GA | LEGAL | $361,029 |
| CORNERSTONE GOVERNMENT AFFAIRS LLC | WASHINGTON, DC | CONSULTING | $181,202 |
2016 · 2 contractors · $514K
| Name | Location | Service | Paid |
|---|---|---|---|
| Pabst Patent Group LLP | Atlanta, GA | legal | $332,454 |
| Cornerstone Government Affairs LLC | Washington, DC | consulting | $181,162 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 1 grant to organizations · $98.5M
2023 · 1 grant to organizations · $89.5M
2022 · 1 grant to organizations · $79.3M
2021 · 1 grant to organizations · $74.5M
2020 · 1 grant to organizations · $72.4M
2019 · 1 grant to organizations · $62.6M
2018 · 1 grant to organizations · $56.8M
2017 · 1 grant to organizations · $57.3M
2016 · 1 grant to organizations · $56.8M
2014 · 1 grant to organizations · $59.5M
2013 · 1 grant to organizations · $55.9M
2011 · 1 grant to organizations · $59.4M
Listed grants add up to $59,396,026; the return's “grants paid” expense line says $61,815,731. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $105,936,769 | $103,146,398 | $29,548,018 | $17,727,133 | $104,971,692 | $0 | $0 | 0 | 0 |
| 2023 · Form 990 | ||||||||
| $95,177,293 | $97,979,370 | $27,613,810 | $14,743,692 | $94,621,065 | $15,737 | $0 | 0 | 0 |
| 2022 · Form 990 | ||||||||
| $85,396,484 | $83,371,484 | $25,123,090 | $17,076,095 | $84,263,029 | $403,598 | $0 | 0 | 0 |
| 2021 · Form 990 | ||||||||
| $80,266,513 | $78,270,820 | $21,382,894 | $15,018,152 | $79,210,374 | $404,987 | $0 | 0 | 0 |
| 2020 · Form 990 | ||||||||
| $78,188,593 | $75,891,088 | $19,929,017 | $13,935,438 | $77,022,959 | $23,668 | $0 | 0 | 0 |
| 2019 · Form 990 | ||||||||
| $66,646,399 | $65,943,506 | $17,324,744 | $10,641,964 | $66,144,266 | $56,300 | $0 | 0 | 0 |
| 2018 · Form 990 | ||||||||
| $61,433,691 | $60,210,072 | $14,292,246 | $9,868,090 | $60,236,160 | $98,907 | $0 | 0 | 0 |
| 2017 · Form 990 | ||||||||
| $61,213,769 | $61,092,773 | $12,735,682 | $8,525,921 | $60,657,292 | $91,692 | $0 | 0 | 0 |
| 2016 · Form 990 | ||||||||
| $60,835,833 | $60,509,713 | $14,011,400 | $8,463,613 | $60,166,858 | $123,221 | $0 | 0 | 2 |
| 2014 · Form 990 | ||||||||
| $63,937,816 | $63,569,912 | $13,099,738 | $7,463,030 | $63,127,478 | $86,848 | $0 | 0 | 3 |
| 2013 · Form 990 | ||||||||
| $59,429,041 | $59,210,705 | $12,736,613 | $7,002,714 | $59,107,663 | $84,374 | $0 | 0 | 3 |
| 2011 · Form 990 | ||||||||
| $63,135,438 | $62,821,300 | $12,589,683 | $6,888,428 | $62,852,474 | $76,623 | $0 | 0 | 0 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- AUGUSTA UNIVERSITY FOUNDATION INC Augusta, GA · 4 people in common (Dr Neil Mackinnon, Jennifer Sullivan Phd, Russell Keen)
- AU HEALTH PROFESSIONS ASSOCIATES INC Augusta, GA · 3 people in common (Dr Andrew Balas, Dr Neil Mackinnon, Russell Keen)
- CENTER FOR GLOBAL HEALTH INNOVATION INC Atlanta, GA · 2 people in common (Dr Chris Mckinney, Dr Michael Diamond)
- GEORGIA REGENTS REAL ESTATE CORPORATION Augusta, GA · 2 people in common (Russell Keen, Yvonne Turner)
- AUGUSTA UNIVERSITY REAL ESTATE Augusta, GA · 2 people in common (Russell Keen, Yvonne Turner)
- MEDICAL COLLEGE OF GEORGIA FOUNDATION INC Augusta, GA · 1 person in common (Russell Keen)
- AU MEDICAL ASSOCIATES INC Marietta, GA · 1 person in common (Dr Michael Diamond)
- GEORGIA RESEARCH ALLIANCE INC Atlanta, GA · 1 person in common (Russell Keen)
- GEORGIA CHAMBER OF COMMERCE INC Atlanta, GA · 1 person in common (Russell Keen)
- UNITED WAY OF THE CENTRAL SAVANNAH RIVER AREA INC Augusta, GA · 1 person in common (Russell Keen)
- CHAMBER OF COMMERCE OF GREATER AUGUSTA GEORGIA,INC Augusta, GA · 1 person in common (Russell Keen)
- PEACH BELT ATHETIC CONFERENCE INC Augusta, GA · 1 person in common (Russell Keen)
- COLUMBIA CTY CHAMBER OF COMMERCE Evans, GA · 1 person in common (Russell Keen)
- AUGUSTA UNIVERSITY Augusta, GA · related organization (Schedule R)
Funders of this organization
105 grantors reported grants to this organization, $63,337,806 in all, tax years 2008 to 2025; the 25 largest shown (all 105). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| AMERICAN HEART ASSOCIATION INC | $30,673,480 | 13 | $6,725,406 | 2024 | 2010-2018, 2020, 2022-2024 | Public charity | Exact | show |
| CYSTIC FIBROSIS FOUNDATION | $4,041,733 | 20 | $396,301 | 2024 | 2017-2024 | Public charity | Exact | show |
| THE MEDICAL COLLEGE OF WISCONSIN INC | $2,404,488 | 9 | $15,235 | 2024 | 2010-2012, 2014, 2019-2022, 2024 | Public charity | Exact | show |
| JOHNS HOPKINS UNIVERSITY | $2,386,311 | 10 | $56,827 | 2024 | 2015-2024 | DAF sponsor | Exact | show |
| ALEXS LEMONADE STAND FOUNDATION | $2,181,211 | 12 | $42,694 | 2025 | 2013-2018, 2020-2025 | Public charity | Exact | show |
| EMORY UNIVERSITY | $1,827,887 | 14 | $642,317 | 2024 | 2010, 2012-2024 | Public charity | Exact | show |
| VANDERBILT UNIVERSITY | $1,671,691 | 4 | $141,591 | 2024 | 2021-2024 | DAF sponsor | Exact | show |
| SCRIPPS RESEARCH INSTITUTE | $1,550,313 | 2 | $728,286 | 2024 | 2023-2024 | Public charity | Exact | show |
| GEORGIA CENTER FOR ONCOLOGY RESEARCH AND EDUCATION INC | $1,185,921 | 5 | $323,129 | 2024 | 2020-2024 | Public charity | Exact | show |
| YALE UNIVERSITY | $955,700 | 10 | $5,341 | 2023 | 2009-2010, 2015-2021, 2023 | DAF sponsor | Exact | show |
| BREAKTHROUGH T1D | $906,559 | 3 | $110,889 | 2016 | 2009-2010, 2016 | Public charity | Exact | show |
| DIALYSIS CLINIC INC | $684,370 | 9 | $74,041 | 2020 | 2011-2014, 2016-2020 | Public charity | Exact | show |
| THOMAS JEFFERSON UNIVERSITY | $593,576 | 5 | $252,841 | 2022 | 2009, 2019-2022 | Public charity | Exact | show |
| HYUNDAI HOPE ON WHEELS | $500,000 | 3 | $200,000 | 2024 | 2021-2022, 2024 | Public charity | Exact | show |
| TRUSTEES OF BOSTON UNIVERSITY | $450,707 | 6 | $51,095 | 2023 | 2018-2023 | Public charity | Exact | show |
| ALZHEIMERS DISEASE AND RELATED DISORDERS ASSOCIATION INC | $449,996 | 2 | $199,999 | 2024 | 2023-2024 | Public charity | Exact | show |
| NEW YORK MEDICAL COLLEGE | $419,363 | 5 | $133,390 | 2024 | 2019-2020, 2022-2024 | Public charity | Exact | show |
| THE STANLEY MEDICAL RESEARCH INSTITUTE | $416,098 | 7 | $29,547 | 2024 | 2016-2021, 2024 | Public charity | Exact | show |
| CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC | $413,796 | 4 | $65,556 | 2017 | 2014-2017 | Public charity | Exact | show |
| HHT FOUNDATION INTERNATIONAL INC | $382,976 | 3 | $151,338 | 2024 | 2022-2024 | Public charity | Exact | show |
| CANNONBALL KIDS CANCER FOUNDATION INC | $370,000 | 3 | $80,000 | 2022 | 2018-2019, 2022 | Public charity | Exact | show |
| BLOOD CANCER UNITED INC | $344,189 | 1 | $344,189 | 2012 | 2012 | Public charity | Exact | show |
| American Diabetes Association Research Foundation Inc | $321,579 | 3 | $5,046 | 2013 | 2010, 2012-2013 | Public charity | Exact | show |
| KNIGHTS TEMPLAR EYE FOUNDATION INC | $310,000 | 7 | $80,000 | 2024 | 2019-2024 | Public charity | Exact | show |
| UNIVERSITY OF PITTSBURGH | $306,780 | 6 | $23,957 | 2017 | 2009-2010, 2014-2017 | Public charity | Exact | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| KANSAS CITY UNIVERSITY | MO | B50 | $165,535,312 | $113,163,958 | PRESIDENT AND CEO | $1,326,126 | Same NTEE code B50, revenue within 2x |
| CONCORDIA UNIVERSITY | NE | B50 | $79,595,642 | $76,230,845 | PROVOST | $321,161 | Same NTEE code B50, revenue within 2x |
| HUSSON UNIVERSITY | ME | B50 | $94,887,660 | $98,414,091 | Past President (Term End 6/24) | $544,248 | Same NTEE code B50, revenue within 2x |
| PARKER UNIVERSITY | TX | B50 | $93,806,640 | $94,372,640 | President | $660,754 | Same NTEE code B50, revenue within 2x |
| TOURO UNIVERSITY NEVADA | NV | B50 | $74,769,274 | $69,067,656 | PRESIDENT, CEO AND TRUSTEE | $1,361,965 | Same NTEE code B50, revenue within 2x |
| DOMINICAN UNIVERSITY OF CALIFORNIA | CA | B50 | $91,946,453 | $94,570,456 | PRESIDENT | $515,883 | Same NTEE code B50, revenue within 2x |
| SAMUEL MERRITT UNIVERSITY | CA | B50 | $134,762,793 | $109,097,319 | President | $989,785 | Same NTEE code B50, revenue within 2x |
| SOUTHERN CALIFORNIA UNIVERSITY OF HEALTH SCIENCES | CA | B50 | $58,961,495 | $57,864,618 | PRESIDENT | $701,562 | Same NTEE code B50, revenue within 2x |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES GROUP RETURN | NC | B50 | $106,748,590 | $88,185,647 | CHAIR & PRESIDENT | $7,634,720 | Same NTEE code B50, revenue within 2x |
| MOODY BIBLE INSTITUTE OF CHICAGO | IL | B50 | $129,574,445 | $134,764,263 | President & CEO | $398,176 | Same NTEE code B50, revenue within 2x |
| KETTERING UNIVERSITY | MI | B50 | $98,177,252 | $101,286,160 | President | $1,017,881 | Same NTEE code B50, revenue within 2x |
| PACIFIC NORTHWEST UNIVERSITY OF HEALTH SCIENCES | WA | B50 | $55,770,104 | $47,691,871 | Dean, COM | $459,661 | Same NTEE code B50, revenue within 2x |
| MARSHALL B KETCHUM UNIVERSITY | CA | B50 | $82,867,618 | $43,764,930 | PRESIDENT | $590,570 | Same NTEE code B50, revenue within 2x |
| COLUMBIA INTERNATIONAL UNIVERSITY | SC | B50 | $71,013,416 | $69,446,362 | PRESIDENT | $390,514 | Same NTEE code B50, revenue within 2x |
| DES MOINES UNIVERSITY OSTEOPATHIC MEDICAL CENTER | IA | B50 | $108,194,264 | $98,768,324 | PRESIDENT, CEO | $1,102,894 | Same NTEE code B50, revenue within 2x |
| WESTERN MICHIGAN UNIVERSITY HOMER STRYKER M D SCHOOL OF MEDICINE | MI | B50 | $133,629,473 | $130,436,181 | DEAN | $650,937 | Same NTEE code B50, revenue within 2x |
| MEDICAL COLLEGE OF WISCONSON AFFILIATED HOSPITALS INC | WI | B50 | $95,407,459 | $95,742,219 | EXECUTIVE DIRECTOR | $616,758 | Same NTEE code B50, revenue within 2x |
| NEW ENGLAND LAW BOSTON | MA | B50 | $71,462,116 | $57,270,490 | ACTING DEAN | $405,743 | Same NTEE code B50, revenue within 2x |
| MILWAUKEE SCHOOL OF ENGINEERING | WI | B50 | $211,353,854 | $190,175,200 | PRESIDENT | $670,202 | Same NTEE code B50, revenue within 2x |
| KAISER PERMANENTE BERNARD J TYSON SCHOOL OF MEDICINE INC | CA | B50 | $115,416,686 | $106,334,559 | EVP,Chief Legal Officer & Secy | $2,623,191 | Same NTEE code B50, revenue within 2x |
| ACCREDITATION COUNCIL FOR GRADUATE MEDICAL EDUCATION | IL | B50 | $88,540,135 | $88,284,548 | PRESIDENT AND CHIEF EXECUTIVE OFFICE | $1,136,938 | Same NTEE code B50, revenue within 2x |
| BANK STREET COLLEGE OF EDUCATION | NY | B50 | $90,806,344 | $91,739,328 | PRESIDENT | $907,983 | Same NTEE code B50, revenue within 2x |
| MITCHELL HAMLINE SCHOOL OF LAW | MN | B50 | $61,940,378 | $59,705,464 | PROFESSOR OF LAW | $341,648 | Same NTEE code B50, revenue within 2x |
| PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE | PA | B50 | $198,027,292 | $183,969,696 | PRESIDENT & CEO | $1,272,390 | Same NTEE code B50, revenue within 2x |
| DALLAS THEOLOGICAL SEMINARY | TX | B50 | $73,352,068 | $67,752,565 | President | $412,262 | Same NTEE code B50, revenue within 2x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $103,146,398 spent · pay $0 · grants $98,471,492 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $98,471,492 | $98,471,492 | - | - | 95.5% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $3,488,706 | $3,488,706 | - | - | 3.4% |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $907,018 | $907,018 | - | - | 0.9% |
| Other (as described) | PERSONNEL EXPENSE | $141,387 | - | $141,387 | - | 0.1% |
| Fees: accounting | $49,441 | - | $49,441 | - | 0.0% | |
| Other (as described) | SUPPLIES AND EQUIPMENT | $46,557 | - | $46,557 | - | 0.0% |
| Fees: legal | $10,108 | - | $10,108 | - | 0.0% | |
| Fees: investment management | $8,728 | - | $8,728 | - | 0.0% | |
| Insurance | $8,054 | - | $8,054 | - | 0.0% | |
| Travel | $6,974 | - | $6,974 | - | 0.0% | |
| Fees: other services | $3,473 | - | $3,473 | - | 0.0% | |
| Information technology | $2,860 | - | $2,860 | - | 0.0% | |
| Office expenses | $1,600 | - | $1,600 | - | 0.0% | |
| Total | $103,146,398 | 100% |
2023 · Form 990 · $97,979,370 spent · pay $0 · grants $89,475,939 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $89,475,939 | $89,475,939 | - | - | 91.3% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $7,092,702 | $7,092,702 | - | - | 7.2% |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $1,173,277 | $1,173,277 | - | - | 1.2% |
| Other (as described) | PERSONNEL EXPENSE | $93,749 | - | $93,749 | - | 0.1% |
| Other (as described) | SUPPLIES AND EQUIPMENT | $50,529 | - | $50,529 | - | 0.1% |
| Fees: accounting | $42,225 | - | $42,225 | - | 0.0% | |
| Fees: legal | $15,054 | - | $15,054 | - | 0.0% | |
| Travel | $12,042 | - | $12,042 | - | 0.0% | |
| Insurance | $7,809 | - | $7,809 | - | 0.0% | |
| Occupancy | $6,293 | - | $6,293 | - | 0.0% | |
| Fees: investment management | $5,651 | - | $5,651 | - | 0.0% | |
| Information technology | $2,600 | - | $2,600 | - | 0.0% | |
| Fees: other services | $1,500 | - | $1,500 | - | 0.0% | |
| Total | $97,979,370 | 100% |
2022 · Form 990 · $83,371,484 spent · pay $0 · grants $79,335,239 · events $91
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $79,335,239 | $79,335,239 | - | - | 95.2% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $3,141,990 | $3,141,990 | - | - | 3.8% |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $301,391 | $301,391 | - | - | 0.4% |
| Royalties | $262,834 | $262,834 | - | - | 0.3% | |
| Other (as described) | PERSONNEL EXPENSE | $193,123 | - | $193,123 | - | 0.2% |
| Other (as described) | SUPPLIES AND EQUIPMENT | $42,207 | - | $42,207 | - | 0.1% |
| Fees: accounting | $37,600 | - | $37,600 | - | 0.0% | |
| Fees: legal | $21,984 | - | $21,984 | - | 0.0% | |
| Travel | $7,618 | - | $7,618 | - | 0.0% | |
| Occupancy | $6,343 | - | $6,343 | - | 0.0% | |
| Insurance | $6,122 | - | $6,122 | - | 0.0% | |
| Fees: investment management | $5,526 | - | $5,526 | - | 0.0% | |
| Fees: other services | $4,195 | - | $4,195 | - | 0.0% | |
| Office expenses | $2,856 | - | $2,856 | - | 0.0% | |
| Information technology | $2,365 | - | $2,365 | - | 0.0% | |
| Conferences, conventions and meetings | $91 | - | $91 | - | 0.0% | |
| Total | $83,371,484 | 100% |
2021 · Form 990 · $78,270,820 spent · pay $0 · grants $74,521,300 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $74,521,300 | $74,521,300 | - | - | 95.2% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $3,142,541 | $3,142,541 | - | - | 4.0% |
| Royalties | $288,877 | $288,877 | - | - | 0.4% | |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $93,078 | $93,078 | - | - | 0.1% |
| Fees: legal | $62,981 | - | $62,981 | - | 0.1% | |
| Other (as described) | PERSONNEL EXPENSE | $50,695 | - | $50,695 | - | 0.1% |
| Other (as described) | SUPPLIES AND EQUIPMENT | $47,396 | - | $47,396 | - | 0.1% |
| Fees: accounting | $25,840 | - | $25,840 | - | 0.0% | |
| Office expenses | $12,867 | - | $12,867 | - | 0.0% | |
| Travel | $7,879 | - | $7,879 | - | 0.0% | |
| Insurance | $5,944 | - | $5,944 | - | 0.0% | |
| Fees: investment management | $5,772 | - | $5,772 | - | 0.0% | |
| Fees: other services | $3,400 | - | $3,400 | - | 0.0% | |
| Information technology | $2,250 | - | $2,250 | - | 0.0% | |
| Total | $78,270,820 | 100% |
2020 · Form 990 · $75,891,088 spent · pay $0 · grants $72,434,342 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $72,434,342 | $72,434,342 | - | - | 95.4% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $2,128,142 | $2,128,142 | - | - | 2.8% |
| Royalties | $498,812 | $498,812 | - | - | 0.7% | |
| Fees: legal | $336,525 | $313,215 | $23,310 | - | 0.4% | |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $236,236 | $236,236 | - | - | 0.3% |
| All other expenses | $79,189 | $79,189 | - | - | 0.1% | |
| Other (as described) | PERSONNEL EXPENSE | $61,483 | - | $61,483 | - | 0.1% |
| Other (as described) | SUPPLIES AND EQUIPMENT | $60,451 | - | $60,451 | - | 0.1% |
| Fees: accounting | $26,700 | - | $26,700 | - | 0.0% | |
| Office expenses | $10,141 | - | $10,141 | - | 0.0% | |
| Fees: investment management | $5,890 | - | $5,890 | - | 0.0% | |
| Fees: other services | $5,588 | - | $5,588 | - | 0.0% | |
| Insurance | $5,404 | - | $5,404 | - | 0.0% | |
| Information technology | $2,185 | - | $2,185 | - | 0.0% | |
| Total | $75,891,088 | 100% |
2019 · Form 990 · $65,943,506 spent · pay $0 · grants $62,595,203 · events $310
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $62,595,203 | $62,595,203 | - | - | 94.9% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $2,310,149 | $2,310,149 | - | - | 3.5% |
| Fees: legal | $373,877 | $361,404 | $12,473 | - | 0.6% | |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $154,698 | $154,698 | - | - | 0.2% |
| Royalties | $144,375 | $144,375 | - | - | 0.2% | |
| Other (as described) | PERSONNEL EXPENSE | $141,405 | - | $141,405 | - | 0.2% |
| All other expenses | $103,648 | $48,061 | $55,587 | - | 0.2% | |
| Other (as described) | AU SUPPORT | $65,326 | $65,326 | - | - | 0.1% |
| Fees: accounting | $25,040 | - | $25,040 | - | 0.0% | |
| Fees: investment management | $7,138 | - | $7,138 | - | 0.0% | |
| Office expenses | $6,432 | - | $6,432 | - | 0.0% | |
| Insurance | $5,404 | - | $5,404 | - | 0.0% | |
| Travel | $5,271 | - | $5,271 | - | 0.0% | |
| Fees: other services | $3,150 | - | $3,150 | - | 0.0% | |
| Information technology | $2,080 | - | $2,080 | - | 0.0% | |
| Conferences, conventions and meetings | $310 | - | $310 | - | 0.0% | |
| Total | $65,943,506 | 100% |
2018 · Form 990 · $60,210,072 spent · pay $0 · grants $56,760,271 · events $1,944
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $56,760,271 | $56,760,271 | - | - | 94.3% | |
| Other (as described) | AU SUPPORT RESEARCH SUB | $2,021,438 | $2,021,438 | - | - | 3.4% |
| Royalties | $659,532 | $659,532 | - | - | 1.1% | |
| Fees: legal | $340,726 | $333,282 | $7,444 | - | 0.6% | |
| All other expenses | $110,740 | $110,740 | - | - | 0.2% | |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $79,699 | $79,699 | - | - | 0.1% |
| Occupancy | $62,612 | - | $62,612 | - | 0.1% | |
| Other (as described) | AU SUPPORT | $57,749 | $57,749 | - | - | 0.1% |
| Other (as described) | PERSONNEL EXPENSE | $57,573 | - | $57,573 | - | 0.1% |
| Fees: accounting | $24,424 | - | $24,424 | - | 0.0% | |
| Travel | $10,829 | - | $10,829 | - | 0.0% | |
| Fees: investment management | $6,854 | - | $6,854 | - | 0.0% | |
| Insurance | $5,404 | - | $5,404 | - | 0.0% | |
| Office expenses | $4,424 | - | $4,424 | - | 0.0% | |
| Fees: other services | $3,963 | - | $3,963 | - | 0.0% | |
| Conferences, conventions and meetings | $1,944 | - | $1,944 | - | 0.0% | |
| Information technology | $1,890 | - | $1,890 | - | 0.0% | |
| Total | $60,210,072 | 100% |
2017 · Form 990 · $61,092,773 spent · pay $0 · grants $57,289,500 · events $946
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $57,289,500 | $57,289,500 | - | - | 93.8% | |
| Other (as described) | AU SUPPORTRESEARCH SUBC | $2,097,990 | $2,097,990 | - | - | 3.4% |
| Other (as described) | TECHNOLOGY TRANSFER OPE | $430,912 | $430,912 | - | - | 0.7% |
| Other (as described) | JINFINITI EXPENSE | $430,780 | $430,780 | - | - | 0.7% |
| Fees: legal | $314,599 | $298,761 | $15,838 | - | 0.5% | |
| Royalties | $216,594 | $216,594 | - | - | 0.4% | |
| Other (as described) | AU SUPPORT | $97,547 | $97,547 | - | - | 0.2% |
| All other expenses | $91,254 | $47,959 | $43,295 | - | 0.1% | |
| Occupancy | $61,399 | - | $61,399 | - | 0.1% | |
| Fees: accounting | $23,800 | - | $23,800 | - | 0.0% | |
| Travel | $14,531 | - | $14,531 | - | 0.0% | |
| Office expenses | $10,245 | - | $10,245 | - | 0.0% | |
| Fees: investment management | $5,617 | - | $5,617 | - | 0.0% | |
| Insurance | $5,404 | - | $5,404 | - | 0.0% | |
| Information technology | $1,655 | - | $1,655 | - | 0.0% | |
| Conferences, conventions and meetings | $946 | - | $946 | - | 0.0% | |
| Total | $61,092,773 | 100% |
2016 · Form 990 · $60,509,713 spent · pay $0 · grants $56,764,724 · events $2,729
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $56,764,724 | $56,764,724 | - | - | 93.8% | |
| Other (as described) | AU supportresearch subc | $2,013,375 | $2,013,375 | - | - | 3.3% |
| Other (as described) | TECHNOLOGY TRaNSFER | $832,339 | $832,339 | - | - | 1.4% |
| Royalties | $313,305 | $313,305 | - | - | 0.5% | |
| Office expenses | $290,623 | - | $290,623 | - | 0.5% | |
| Other (as described) | jinfiniti expense | $105,600 | $105,600 | - | - | 0.2% |
| Other (as described) | au support | $69,195 | $69,195 | - | - | 0.1% |
| All other expenses | $35,735 | $35,735 | - | - | 0.1% | |
| Fees: accounting | $23,250 | - | $23,250 | - | 0.0% | |
| Travel | $15,595 | - | $15,595 | - | 0.0% | |
| Fees: investment management | $14,117 | - | $14,117 | - | 0.0% | |
| Occupancy | $11,368 | - | $11,368 | - | 0.0% | |
| Fees: legal | $7,979 | - | $7,979 | - | 0.0% | |
| Insurance | $5,404 | - | $5,404 | - | 0.0% | |
| Conferences, conventions and meetings | $2,729 | - | $2,729 | - | 0.0% | |
| Fees: management | $2,720 | - | $2,720 | - | 0.0% | |
| Information technology | $1,655 | - | $1,655 | - | 0.0% | |
| Total | $60,509,713 | 100% |
2014 · Form 990 · $63,569,912 spent · pay $0 · grants $59,484,688 · events $2,827
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $59,484,688 | $59,484,688 | - | - | 93.6% | |
| Other (as described) | RESEARCH SUBCONTRACTED | $2,312,471 | $2,312,471 | - | - | 3.6% |
| Other (as described) | TECHNOLOGY TRANSFER | $637,217 | $637,217 | - | - | 1.0% |
| Royalties | $575,979 | $575,979 | - | - | 0.9% | |
| Other (as described) | GRU EXP REIMB TO DSPA G | $187,889 | $187,889 | - | - | 0.3% |
| Office expenses | $136,765 | - | $136,765 | - | 0.2% | |
| Other (as described) | LIFE SCIENCE BUSINESS D | $126,940 | - | $126,940 | - | 0.2% |
| All other expenses | $26,659 | $25,000 | $1,659 | - | 0.0% | |
| Fees: accounting | $23,800 | - | $23,800 | - | 0.0% | |
| Travel | $20,543 | - | $20,543 | - | 0.0% | |
| Fees: legal | $18,013 | - | $18,013 | - | 0.0% | |
| Occupancy | $9,780 | - | $9,780 | - | 0.0% | |
| Insurance | $4,906 | - | $4,906 | - | 0.0% | |
| Conferences, conventions and meetings | $2,827 | - | $2,827 | - | 0.0% | |
| Information technology | $1,435 | - | $1,435 | - | 0.0% | |
| Total | $63,569,912 | 100% |
2013 · Form 990 · $59,210,705 spent · pay $0 · grants $55,945,361 · events $2,890
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $55,945,361 | $55,945,361 | - | - | 94.5% | |
| Other (as described) | RESEARCH SUBCONTRACTED | $1,969,236 | $1,969,236 | - | - | 3.3% |
| Other (as described) | TECHNOLOGY TRANSFER | $646,033 | $646,033 | - | - | 1.1% |
| Other (as described) | GRU EXP REIMB TO DSPA G | $186,635 | - | $186,635 | - | 0.3% |
| Office expenses | $146,150 | - | $146,150 | - | 0.2% | |
| Other (as described) | LIFE SCIENCE BUSINESS D | $144,661 | $144,661 | - | - | 0.2% |
| Royalties | $90,264 | $90,264 | - | - | 0.2% | |
| All other expenses | $26,729 | - | $26,729 | - | 0.0% | |
| Fees: accounting | $23,200 | - | $23,200 | - | 0.0% | |
| Fees: legal | $19,599 | - | $19,599 | - | 0.0% | |
| Insurance | $4,807 | - | $4,807 | - | 0.0% | |
| Conferences, conventions and meetings | $2,890 | - | $2,890 | - | 0.0% | |
| Travel | $2,305 | - | $2,305 | - | 0.0% | |
| Fees: other services | $1,800 | - | $1,800 | - | 0.0% | |
| Information technology | $1,035 | - | $1,035 | - | 0.0% | |
| Total | $59,210,705 | 100% |
2011 · Form 990 · $62,821,300 spent · pay $0 · grants $61,815,731 · events $847
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Grants to US organizations and governments | $61,815,731 | $61,815,731 | - | - | 98.4% | |
| Other (as described) | TECHNOLOGY TRANSFER | $678,103 | $678,103 | - | - | 1.1% |
| Other (as described) | LIFE SCIENCE BUSINESS D | $182,417 | $182,417 | - | - | 0.3% |
| Other (as described) | GHSU EXP REIMB TO DSPA | $46,806 | - | $46,806 | - | 0.1% |
| Other (as described) | MEMBERSHIP DUES | $25,000 | - | $25,000 | - | 0.0% |
| Fees: accounting | $24,000 | - | $24,000 | - | 0.0% | |
| All other expenses | $19,206 | - | $19,206 | - | 0.0% | |
| Fees: legal | $14,198 | - | $14,198 | - | 0.0% | |
| Office expenses | $9,057 | - | $9,057 | - | 0.0% | |
| Insurance | $4,280 | - | $4,280 | - | 0.0% | |
| Information technology | $930 | - | $930 | - | 0.0% | |
| Conferences, conventions and meetings | $847 | - | $847 | - | 0.0% | |
| Travel | $725 | - | $725 | - | 0.0% | |
| Total | $62,821,300 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2026 | $150,000 | 3 | |
| 2025 | $200,000 | 4 | |
| 2024 | $200,000 | 4 | |
| 2023 | $200,000 | 4 | |
| 2022 | $200,000 | 4 | |
| 2021 | $200,000 | 4 | |
| 2020 | $200,000 | 4 | |
| 2019 | $200,000 | 4 | |
| 2018 | $200,000 | 4 | |
| 2017 | $200,000 | 4 | |
| 2016 | $200,000 | 4 | |
| 2015 | $200,000 | 4 | |
| 2014 | $190,000 | 4 | |
| 2013 | $160,000 | 5 |
Issues: Defense, Health Issues, Education, Budget/Appropriations, Medicare/Medicaid, Veterans
Firms hired: CORNERSTONE GOVERNMENT AFFAIRS, INC.
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | $0 | -$26,773 | 5 |
| 2026 | $61,237,915 | $211,397 | 215 |
| 2025 | $64,266,112 | $248,712 | 217 |
| 2024 | $75,017,866 | $172,750 | 239 |
| 2023 | $69,748,964 | $11,480 | 214 |
| 2022 | $62,051,088 | $186,069 | 202 |
| 2021 | $64,143,695 | $207,547 | 186 |
| 2020 | $54,283,057 | $113,287 | 172 |
| 2019 | $52,384,728 | $221,598 | 173 |
| 2018 | $51,325,774 | $3,976 | 150 |
| 2017 | $46,889,575 | $42,876 | 155 |
| 2016 | $48,729,200 | $182,480 | 136 |
| 2015 | $46,601,510 | $267,722 | 130 |
| 2014 | $43,091,670 | $314,701 | 133 |
| 2013 | $46,863,864 | $154,582 | 121 |
| 2012 | $49,432,887 | $29,100 | 132 |
| 2011 | $50,166,502 | $113,450 | 139 |
| 2010 | $54,730,098 | $706,613 | 154 |
| 2009 | $54,417,699 | $1,131,512 | 157 |
| 2008 | $23,706,516 | $365,154 | 89 |
| 2007 | $29,336,863 | $194,859 | 103 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2027 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$9 |
| 2027 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$472 |
| 2027 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$26,291 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE CELL INTERACTIONS IN ATHEROSCLEROSIS | $2,311,266 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGE-INDUCED IMPAIRMENT OF NUTRIENT SIGNALING RESULTS IN BONE LOSS | $2,262,480 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ENDOTHELIAL METABOLISM AND REDOX IMBALANCE IN VASCULAR DISEASE - PROJECT SUMMARY REDOX IMBALANCE BETWEEN REACTIVE OXYGEN SPECIES (ROS) AND REACTIVE NITROGEN SPE | $2,218,816 |
| 2026 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | CYBERAI SFS: GOVERNMENT-READY EXPERTS IN RESILIENT CYBERAI -THERE IS A GROWING NATIONAL NEED FOR PROFESSIONALS WHO CAN SECURE ARTIFICIAL INTELLIGENCE SYSTEMS AN | $1,999,098 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMPROVING AWARENESS OF WOMEN WITH HYPERTENSION: ROAR (RURAL, OBESE, AT RISK) - MORE THAN 1 IN 3 WOMEN ARE LIVING WITH HEART DISEASE AND MANY ARE UNAWARE OF THE | $1,460,600 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CONTROL 93.399 | GEORGIA CARES | $1,304,406 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CALCULATOR FOR LENGTH OF USE OF BISPHOSPHONATES (CLUB) - OSTEOPOROTIC FRACTURES ARE A MAJOR PUBLIC HEALTH PROBLEM, ESPECIALLY FOR OLDER PERSONS. BISPHOSPHONATES | $1,171,961 |
| 2026 | Substance Abuse and Mental Health Services Administration | Grant or other assistance | CENTER FOR SUBSTANCE ABUSE TREATMENT PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE 93.490 | THE REGIONAL EXPANSION OF OVERDOSE INTERVENTIONS TO REDUCE ER VISITS AND DEATHS IN GEORGIA (REVIVE GEORGIA) - THE REGIONAL EXPANSION OF OVERDOSE INTERVENTIONS T | $850,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | WRESTLING STRESS: ROLE OF UFM1 MODIFICATION IN PATHOLOGICAL CARDIAC REMODELING | $764,665 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NOVEL MECHANISMS OF HIV-ASSOCIATED PULMONARY VASCULAR DISEASE - PROJECT SUMMARY THANKS TO THE ADVENT OF COMBINATION ANTIRETROVIRAL THERAPY (CART), LIFE EXPECTAN | $760,760 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DARC, INFLAMMAGING AND ALZHEIMER'S DISEASE - PROJECT SUMMARY CHRONIC INFLAMMATION OF THE BRAIN OCCURS WITH AGING AND PLAYS AN IMPORTANT ROLE IN AGE-RELATED COGN | $759,146 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTION AND TRANSCRIPTIONAL REGULATION OF LEIOMODIN1 - PROJECT SUMMARY RECENT LINEAGE TRACING AND SINGLE CELL OMICS STUDIES PROVIDE IRREFUTABLE EVIDENCE FOR VA | $752,834 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SKELETAL MUSCLE HEALTH PROTECTS VASCULAR FUNCTION IN OBESITY - PROJECT SUMMARY OBESITY REMAINS THE MOST PERSISTENT THREAT TO CARDIOVASCULAR HEALTH IN THE UNITE | $751,582 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | POSTTRANSLATIONAL CONTROL OF VSMC IDENTITY AND VASCULAR HEALTH - THE PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS (VSMCS) FROM A CONTRACTILE TO A PROLIF | $751,335 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF VASCULAR SMOOTH MUSCLE CELL-ENRICHED LNCRNA IN ATHEROSCLEROSIS - PROJECT SUMMARY VASCULAR SMOOTH MUSCLE CELLS (VSMCS) PLAY A PIVOTAL ROLE IN THE INITIA | $750,414 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | RURAL HEALTHCARE SERVICES PROGRAMS 93.912 | RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT - THE RURAL EXPANSION OF SUBSTANCE USE PREVENTION, TREATMENT, OUTREACH, RECOVERY, AND ENGAGEMENT (RESTORE) PROJ | $750,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CU UPTAKE TRANSPORTER AS A DISTURBED FLOW SENSOR IN VASCULAR INFLAMMATORY DISEASE - PROJECT SUMMARY THE AIM OF THIS GRANT IS TO ELUCIDATE THE NOVEL ROLE OF ENDO | $747,054 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | HARNESSING MYELOID OLFACTORY RECEPTORS TO REPROGRAM TUMOR IMMUNITY - PROJECT SUMMARY MELANOMA, AN AGGRESSIVE SKIN CANCER WHOSE INCIDENCE CONTINUES TO RISE, WITH | $731,500 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GUT-IMMUNE-KIDNEY AXIS, HYPERTENSION, AND RENAL END-ORGAN DAMAGE - PROJECT SUMMARY/ABSTRACT NEARLY HALF OF THE ~120 MILLION AMERICANS WITH HYPERTENSION ARE SALT | $707,903 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | IMPACT OF HIV-1 TAT PROTEIN ON COCAINE-DOPAMINE TRANSPORTER INTERACTION | $693,977 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | THE ROLE OF CHD7 IN ACC NEURONS - A LIMITED FUNDAMENTAL UNDERSTANDING OF THE CELLULAR AND MOLECULAR MECHANISMS UNDERLYING COMPLEX BEHAVIORS POSES A MAJOR BARRIE | $689,447 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | IMMUNOMETABOLIC REGULATION AFTER CNS INJURY - TITLE: IMMUNOMETABOLIC REGULATION AFTER CNS INJURY PROGRESSIVE NEURODEGENERATION IS A SEQUELA OF TRAUMATIC BRAIN | $686,654 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ROLE OF AGRP NEURONS IN CHRONIC STRESS-ACCELERATED BRAIN AGING AND PROGRESSION OF ALZHEIMER'S DISEASE - PROJECT SUMMARY CHRONIC STRESS IS INCREASINGLY BEING REC | $686,119 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MOLECULAR CONTROL OF VASCULAR SMOOTH MUSCLE REPROGRAMMING IN ARTERIOVENOUS FISTULA MATURATION - PROJECT SUMMARY A SURGICALLY CREATED ARTERIOVENOUS FISTULA (AVF) | $684,096 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | TARGETING THE CD73-ADENOSINERGIC PATHWAY IN HEAD AND NECK CANCER - HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSC) RELATED TO TOBACCO AND ALCOHOL CONSUMPTION IS AG | $677,163 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS OF HIV-ASSOCIATED HYPERTENSION - PROJECT SUMMARY OVER THE LAST FEW DECADES, THE ADVENT OF COMBINATION ANTIRETROVIRAL THERAPY HAS LED TO A PROFOUND SU | $669,900 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING STK3 TO MITIGATE CHEMOTHERAPY INDUCED CARDIOTOXICITY - ABSTRACT BREAST CANCER (BCA) SURVIVAL HAS IMPROVED SUBSTANTIALLY, YET THE CARDIOTOXIC EFFECTS O | $655,885 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ELUCIDATING THE ROLE OF CULLIN 3 IN THE HEART - PROJECT SUMMARY CARDIOMYOCYTE (CM) MITOCHONDRIA PLAY A CRUCIAL ROLE IN ENERGY PRODUCTION AND OTHER ESSENTIAL CEL | $654,066 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | VASCULAR SMOOTH MUSCLE PROTEIN QUALITY CONTROL AND AORTIC ANEURYSM FORMATION - PROJECT SUMMARY ABDOMINAL AORTIC ANEURYSM (AAA) IS A DEVASTATING DISEASE CARRYING | $652,316 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PSYCHOSOCIAL STRESS IN EARLY LIFE, CHRONODISRUPTION AND ACCELERATED AGING IN MID LIFE: A LIFE-COURSE APPROACH - PROJECT SUMMARY AS THE U.S. POPULATION AGES, THE | $646,620 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | EPIGENETIC MECHANISMS OF SELECTIVE VULNERABILITY OF ENTORHINAL PV NEURONS IN AGING AND AD - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS CHARACTERIZED BY THE SEL | $646,073 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF NETRIN-1 IN POLYCYSTIC KIDNEY DISEASE - PROJECT SUMMARY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) IS CAUSED BY MUTATIONS IN THE POLYCYSTIC KI | $645,382 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ASTROCYTIC OSMR/JAK/STAT SIGNALING IN AD - THE ROLE OF REACTIVE ASTROCYTES IN ALZHEIMER’S DISEASE (AD) PATHOGENESIS REMAINS LARGELY UNDERSTUDIED. LITTLE IS KNOW | $641,097 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GUT METABOLITES, T CELLS, AND SALT-SENSITIVE HYPERTENSION - SUMMARY HYPERTENSION IS A PRIMARY MODIFIABLE RISK FACTOR FOR CARDIOVASCULAR, CEREBROVASCULAR, AND RE | $617,262 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | CENTER CORE GRANT FOR VISION RESEARCH | $615,995 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLYCOSAMINOGLYCAN TARGETING TREATMENT FOR PROSTATIC HYPERPLASIA AND FIBROSIS - BENIGN PROSTATIC HYPERPLASIA (BPH) IS AN AGE-RELATED PROGRESSIVE PATHOLOGIC CONDI | $615,750 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | NOVEL MECHANISMS OF MUSCLE AND BONE LOSS WITH HIV INFECTION, ANTIRETROVIRAL THERAPY, AND AGING. - OUR PROPOSAL IS IN DIRECT RESPONSE TO THE SPECIAL FUNDING OPPO | $608,341 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE IMPACT OF BLOOD PRESSURE VARIABILITY ON NEUROVASCULAR FUNCTION - INTRAVASCULAR PRESSURE DRIVES PERFUSION, WHICH IS CRITICAL FOR OPTIMAL NEURONAL FUNCTION. H | $602,910 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TUBULAR HYPERTROPHY AND AKI SUSCEPTIBILITY IN DIABETES - PROJECT SUMMARY DESPITE ADVANCES IN TREATMENT, ACUTE KIDNEY INJURY (AKI) PATIENTS REQUIRING DIALYSIS S | $596,345 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | INVESTIGATING THE MOLECULAR BASIS OF CUTANEOUS MELANOMAS IN NON-CAUCASIAN PATIENTS TRANSFER AWARD FOR AUGUSTA UNIVERSITY RESEARCH WITH MODIFICATION P00002 | $574,014 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | RED BLOOD CELL TRAPPING MEDIATES TOXIC KIDNEY INJURY FOLLOWING ISCHEMIA - ENTER THE TEXT HERE THAT IS THE NEW ABSTRACT INFORMATION FOR YOUR APPLICATION. THIS SE | $569,179 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CRITICAL ROLE FOR HSF2 AND HSP110 AXIS IN REGULATION OF PRE-MRNA SPLICING AND RADIATION RESPONSE - ABSTRACT PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) HAS A POOR 5 | $568,713 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NEURONAL HDAC9, SYNAPTIC PLASTICITY AND ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS AN AGE-RELATED NEURODEGENERATIVE DISORDER THAT CAUSES | $567,615 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EPIGENETIC REGULATION OF THE METABOLIC SHIFT IN MAMMALIAN PERINATAL HEARTS - ABSTRACT: DURING THE TRANSITION TO EXTRA-UTERINE LIFE, MAMMALIAN HEARTS UNDERGO A C | $567,286 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | REPARATIVE EFFECT OF JUVENILE FACTORS IN AGING AND INJURY - AGING AND INJURY ARE AMONG THE MAJOR GLOBAL HEALTH PROBLEMS AND DEATH DUE TO INJURY INCREASES SHARPL | $558,872 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE ROLE OF ORAL MICROBIALLY INDUCED EXOSOMES IN ALZHEIMER'S DISEASE PATHOGENESIS - ALZHEIMER’S DISEASE AND RELATED DEMENTIA (ADRD) AFFECT 50 MILLION PEOPLE WOR | $555,247 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | A NOVEL ARTIFICIALLY INDUCIBLE CARGO ASSAY TO PROBE INTRACELLULAR TRANSPORT DEFECTS IN NEURODEVELOPMENTAL DISEASES - PROJECT SUMMARY/ABSTRACT MICROTUBULE-BASED | $555,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SMC MACROPINOCYTOSIS: A NOVEL TARGET IN ATHEROSCLEROTIC VASCULAR DISEASE - PROJECT SUMMARY ATHEROSCLEROSIS IS A LEADING CAUSE OF MORBIDITY AND MORTALITY GLOBALL | $552,402 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | SUPPRESSING THE CO-CHAPERONE UNC45A REPROGRAMS THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT TO FIGHT CANCER - ABSTRACT BREAST CANCER REMAINS ONE OF THE LEADING | $546,397 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NOVEL ROLE OF BSCL2 IN CARDIAC SUBSTRATE METABOLISM AND FUNCTION | $542,697 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SUB-SECOND PHARMACOKINETICS OF ACETYLCHOLINE RELEASE AND RECYCLING IN THE CEREBRAL CORTEX - PROJECT SUMMARY THIS PROJECT WILL INVESTIGATE THE POTENTIAL OF SUB-P | $539,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATION AND ROLE OF LEPTIN IN PREECLAMPSIA - PREECLAMPSIA (PE) IS A HYPERTENSIVE DISEASE IN PREGNANCY THAT IS A LEADING CAUSE OF ADVERSE MATERNAL AND FETAL O | $520,113 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ELUCIDATING UPSTREAM AND DOWNSTREAM NUAK2 MECHANISMS IN NEUROENDOCRINE PROSTATE CANCER - ABSTRACT ALTHOUGH ANDROGEN RECEPTOR (AR) SIGNALING INHIBITORS SUCH AS E | $518,589 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | RISK FACTORS AND PREVENTION OF DEFECTIVE RESULTS IN BIOMEDICAL RESEARCH - PROJECT SUMMARY FINDING AND IMPLEMENTING EVIDENCE-BASED AND EFFECTIVE PRACTICES TO AVO | $511,643 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | SEX-SPECIFIC INFLUENCES ON TEAR MICRORNAS IN DRY EYE DISEASE - PROJECT SUMMARY DRY EYE DISEASE (DED) AFFECTS MILLIONS OF AMERICANS, CAUSING DISCOMFORT, VISION P | $509,679 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EPIGENETIC REPROGRAMMING OF CARDIAC MYOFIBROBLASTS FOR CARDIAC REPAIR - PROJECT SUMMARY HEART FAILURE IS ASSOCIATED WITH ACTIVATION OF CARDIAC FIBROBLASTS (FIB) | $498,828 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MOLECULAR SUBTYPING OF DRY EYE DISEASE: A MACHINE LEARNING APPROACH USING TEAR FLUID PROTEINS - PROJECT SUMMARY DRY EYE DISEASE (DED) IS A PREVALENT OCULAR COND | $495,229 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DEVELOPMENT OF SUV39H1-SELECTIVE INHIBITOR FOR HUMAN COLON CANCER THERAPY - PROJECT SUMMARY ONLY THE MICROSATELLITE INSTABILITY HIGH (MSI-H) HUMAN COLORECTAL C | $486,615 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | INJURY-MECHANISMS OF TASTE BUD REGENERATION - PROJECT SUMMARY THE SENSE OF TASTE IS IMPORTANT FOR NUTRITION AND QUALITY OF LIFE. TASTE BUDS ON THE ANTERIOR TONG | $477,834 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNCOVERING THE PHYSIOLOGICAL ROLE OF FUNCTIONAL HYPEREMIA - NEURONAL ACTIVATION LEADS TO INCREASES IN BLOOD FLOW TO THE REGION. SINCE ITS DISCOVERY IN THE 19TH | $471,041 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ENDOGENOUS STEROID HORMONES AS MEDIATORS OF INTERORGAN COMMUNICATION WITH THE MUSCULOSKELETAL SYSTEM - PROJECT SUMMARY/ABSTRACT: GLUCOCORTICOIDS (GC) ARE MULTIS | $470,599 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | INFLAMMAGING AND DIABETIC RETINOPATHY - PROJECT SUMMARY DIABETIC RETINOPATHY (DR) IS A NEUROVASCULAR COMPLICATION OF DIABETES MELLITUS AND THE LEADING CAUSE OF | $469,854 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SPREADING DEPOLARIZATION IN RELATION TO CYTOTOXIC EDEMA AND CELL DEATH - SPREADING DEPOLARIZATION (SD) IS ASSOCIATED WITH MIGRAINE AURA AND IS RECOGNIZED AS A N | $462,933 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ROLE OF HEAT SHOCK TRANSCRIPTION FACTORS (HSFS) IN HEMATOLOGICAL MALIGNANCIES - ABSTRACT AMONG THE HUMAN HEMATOLOGICAL MALIGNANCIES, ACUTE LEUKEMIA TYPES INCLUD | $462,585 |
| 2026 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | COLLABORATIVE RESEARCH: SOFTWARE ENGINEERING TUTOR - A COHESIVE, INTEGRATED FEEDBACK ENGINE TO SUPPORT INQUIRY-BASED LEARNING OF SOFTWARE ENGINEERING CONCEPTS - | $462,206 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | COORDINATING UNIT FOR THE NATIONAL CENTERS FOR METABOLIC PHENOTYPING IN LIVE MODELS OF OBESITY AND DIABETES (MPMOD) - THE NATIONAL CENTERS FOR METABOLIC PHENOTY | $457,796 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF SUBCLINICAL RENAL INJURY IN FEMALES FOLLOWING AKI: IMPLICATIONS FOR ADVERSE PREGNANCY OUTCOMES - RECENT LARGE-SCALE CLINICAL STUDIES REPORT THAT | $452,213 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL POSTTRANSLATIONAL MODIFICATIONS IN ADIPOSE BIOLOGY - PROJECT SUMMARY METABOLIC HEALTH DEPENDS ON MAINTAINING NORMAL MASS AND FUNCTION OF ADIPOSE TISSUE ( | $445,060 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS 93.732 | ADDICTION MEDICINE FELLOWSHIP - THE RURAL AND UNDERSERVED INTERVENTION AND SUBSTANCE USE EDUCATION (RISE) PROJECT WILL PROVIDE SUSTAINABLE SUBSTANCE USE PREVENT | $434,260 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | BIOMARKER GUIDED COMBINATIONS FOR TREATING HIGH-RISK BLADDER CANCER - BLADDER CANCER (BC) IS A COMMON CANCER OF THE URINARY TRACT. WHILE LOW-GRADE TUMORS HAVE A | $427,777 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | SIGMA-1 RECEPTOR PROVIDES NEUROPROTECTION AGAINST OPTIC NEUROPATHY | $421,655 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | BACTERIA-DERIVED XENOBIOTICS IN COLON CANCER PREVENTION: LINK TO GPR109A AND COLONIC KETOGENESIS - PROJECT SUMMARY: CHEMICAL CARCINOGENS AND XENOBIOTICS IN THE | $419,919 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | GPCR ANTEROGRADE TRAFFICKING | $408,100 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | GENETIC REGULATION OF COCHLEAR DUCT PATTERNING AND PROSENSORY FORMATION - PROJECT SUMMARY SENSORINEURAL DEAFNESS IS TYPICALLY CAUSED BY THE IRREVERSIBLE LOSS OF | $401,832 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ADIPOSE TISSUE DISTRIBUTION DETERMINES MICROGLIAL REGULATION OF HIPPOCAMPAL PLASTICITY | $397,713 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CANCER AT THE CROSSROADS: TRANSLATING SOCIAL CONTEXTS INTO ACTIONABLE INSIGHTS FOR EARLY-ONSET COLORECTAL CANCER CARE (CROSS) - PROJECT SUMMARY/ABSTRACT BACKGRO | $395,973 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ROLE OF HIPPOCAMPAL HCN CHANNELS IN SOCIAL AVOIDANCE - CONTACT PD/PI: KIM, CHUNG SUB ABSTRACT SOCIAL STRESS IN HUMANS INCREASES THE RISK OF MENTAL HEALTH PROBLE | $393,981 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | HDAC3 AS A THERAPEUTIC TARGET FOR INTRACEREBRAL HEMORRHAGE - SECONDARY BRAIN INJURY IS A LEADING CAUSE OF NEUROLOGICAL DEFICITS AFTER INTRACEREBRAL HEMORRHAGE ( | $390,755 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ASTROCYTE-NEURON MECHANISMS OF GLUTAMATERGIC MODULATION IN SOCIAL NOVELTY RECOGNITION - PROJECT SUMMARY SOCIAL BEHAVIOR IS A FUNDAMENTAL COMPONENT OF COMPLEX BE | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | METABOLIC-PURINERGIC FITNESS IN PERIODONTAL HEALTH AND DISEASE - PROJECT SUMMARY DESPITE PERIODONTITIS TYPICALLY MANIFESTING IN LATER STAGES OF LIFE, OUR UNDERS | $389,404 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | SENESCENT PERIODONTAL LIGAMENT CELLS AS A POTENTIAL THERAPEUTIC TARGET FOR AGE-ASSOCIATED PERIODONTITIS - PROJECT SUMMARY/ABSTRACT PERIODONTAL DISEASE (PD) IS A | $385,462 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | TEMPORARY PLASMA MEMBRANE DISRUPTIONS IN CORNEAL EPITHELIUM AND KERATOCYTES. - TRANSIENT PLASMA MEMBRANE DISRUPTIONS (TPMD) ARE MINOR, QUICKLY REPAIRABLE PLASMA | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | TARGETING INTERLEUKIN-6 CIS-TRANS BALANCE IN MÜLLER CELL DYSFUNCTION - PROJECT SUMMARY DIABETIC RETINOPATHY (DR) IS A SIGHT-THREATENING NEUROVASCULOPATHY AND TH | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CONVENTIONAL AND UNCONVENTIONAL GPCR-G PROTEIN COUPLING - PROJECT SUMMARY/ABSTRACT G PROTEIN-COUPLED RECEPTORS (GPCRS) ARE IMPORTANT TARGETS OF HORMONES, NEUROT | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MECHANISMS OF LENS EPITHELIUM FIBROSIS AND ITS RELEVANCE TO POSTERIOR CAPSULE OPACIFICATION - ABSTRACT CATARACT SURGERY IS ASSOCIATED WITH A HIGH RISK OF POSTE | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MECHANISMS AND CONSEQUENCES OF IMPAIRED GLUTATHIONE HOMEOSTASIS IN THE AGING LENS | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR MECHANISMS UNDERLYING THE ESTABLISHMENT OF CELL POLARITY. - A FUNDAMENTAL FEATURE OF EUKARYOTIC LIFE IS THE ESTABLISHMENT AND MAINTENANCE OF CELLULAR | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | TARGETING SIGMA 1 RECEPTOR AS A NOVEL THERAPY FOR LIMITING NEUROVASCULAR INJURY IN ROP - PROJECT SUMMARY RETINOPATHY OF PREMATURITY (ROP) IS A LEADING CAUSE OF | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MYELOID ACAT1 IN ISCHEMIC RETINOPATHY - MYELOID ACAT1 IN ISCHEMIC RETINOPATHY STUDIES IN THE MOUSE MODELS OF OXYGEN-INDUCED RETINOPATHY (OIR) AND DIABETIC RETIN | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | OCULAR MCMV LATENCY AND AMD-LIKE PATHOLOGY - PROJECT SUMMARY AGE-RELATED MACULAR DEGENERATION (AMD) IS THE LEADING CAUSE OF IRREVERSIBLE VISUAL DYSFUNCTION IN O | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | ROLE OF KCTD PROTEINS IN STRIATAL SIGNALING - PROJECT SUMMARY ALTERATIONS IN STRIATAL CAMP SIGNAL TRANSDUCTION CONTRIBUTE TO THE PROGRESSION OF MOVEMENT DISORDE | $385,000 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | G PROTEIN TRAFFICKING IN CARDIOMYOCYTES AND NEURONS - PROJECT SUMMARY/ABSTRACT G PROTEIN-COUPLED RECEPTORS (GPCRS) REGULATE VIRTUALLY EVERY ASPECT OF EXCITABLE | $371,512 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CELL TYPE-SPECIFIC COMPLEMENT ACTIVATION AND GLIAL REACTIVITY IN MALE AND FEMALE MICE WITH DIETARY OBESITY - PROJECT SUMMARY NEUROINFLAMMATION IS A SHARED FEATU | $367,338 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | RURAL HEALTHCARE SERVICES PROGRAMS 93.912 | RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-OVERDOSE RESPONSE - FUNDING WILL SUPPORT A COMPREHENSIVE APPROACH TO ADDRESSING SUBSTANCE USE DISORDER IN FOUR RURAL C | $300,000 |
| 2026 | National Science Foundation | Grant or other assistance | COMPUTER AND INFORMATION SCIENCE AND ENGINEERING 47.070 | COLLABORATIVE RESEARCH: AF: RESOURCE-EFFICIENT BYZANTINE PROTOCOLS -SOCIETY DEPENDS ON THE PERFORMANCE AND INTEGRITY OF DISTRIBUTED NETWORKS THAT SPAN THE GLOBE | $285,952 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MOUSE MODEL OF HYPERSENSITIVITY TO LPS - SUMMARY. IN INVESTIGATION OF THE BALANCE BETWEEN PYROPTOSIS AND NECROPTOSIS MEDIATED BY CASPASE-8 AND RECEPTOR INTERACT | $252,716 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTERROGATING THE ROLE OF GTP METABOLISM IN RAC1-DRIVEN PHENOTYPES IN MELANOMA - PROJECT SUMMARY MALIGNANT MELANOMA IS A VERY AGGRESSIVE FORM OF CANCER IN HUMA | $249,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SPHINGOSINE KINASE 1 PLAYS A KEY ROLE IN DEFECTIVE ELASTIN-INDUCED ARTERIAL HYPERMUSCULARIZATION - PROJECT SUMMARY/ABSTRACT ELASTIN IS THE MAJOR COMPONENT OF C | $249,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | LEVERAGING DROSOPHILA TO IDENTIFY NOVEL AND CONSERVED REGULATORS OF CARDIOMYOCYTE POLYPLOIDY - DURING THE TRANSITION TO ADOLESCENCE, MAMMALIAN CARDIOMYOCYTES SW | $248,976 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | CHRONIC HIV INFECTION AND ISCHEMIC RETINOPATHIES - PROJECT SUMMARY THE OVERALL GOAL OF THIS NOVEL EXPLORATORY PROPOSAL IS TO INVESTIGATE/ASSESS THE POTENTIAL IM | $192,500 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | PERIVASCULAR ADIPOSE TISSUE IN THE PATHOGENESIS OF LUPUS VASCULOPATHY - PROJECT SUMMARY PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE, COMMONLY CALLED LUPUS) | $177,120 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | APPRAISING THE FRACTURE RISK ASSESSMENT TOOL (FRAX) IN PERSONS WITH RHEUMATOID ARTHRITIS - PERSONS WITH RHEUMATOID ARTHRITIS (RA) HAVE UP TO TWO TIMES HIGHER RI | $177,120 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | CLINICIAN-SCIENTIST RESEARCH INCUBATOR FOR PRACTICE-BASED TRAINING (CLIN.SCRIPT) - PROJECT ABSTRACT TRAINING IN CLINICAL DENTAL RESEARCH IS FUNDAMENTAL TO THE P | $174,699 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING NRAS MUTATIONS IN MELANOMA. - SCIENTIFIC ABSTRACT METASTATIC MELANOMA IS A LETHAL CANCER ESTIMATED TO HAVE CAUSED APPROXIMATELY 8,000 DEATHS IN THE UN | $154,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | JUNCTIONAL MECHANISMS OF HDAC7-MEDIATED LUNG ENDOTHELIAL BARRIER REGULATION - PROJECT SUMMARY ACUTE LUNG INJURY (ALI) IS CHARACTERIZED BY LUNG VASCULAR ENDOTHEL | $136,593 |
| 2026 | Washington Headquarters Services | Grant or other assistance | INFORMATION SECURITY GRANTS 12.902 | FISCAL YEAR 2025 DEPARTMENT OF DEFENSE CHIEF INFORMATION OFFICER CYBER SERVICE ACADEMY SCHOLARSHIPS: AUGUSTA UNIVERSITY | $129,071 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROGRAM FOR AGING RESEARCH IN THE SUMMER (PARIS) - WORLDWIDE THERE ARE ABOUT 617 MILLION PEOPLE AGED 65 OR OLDER, AND THIS POPULATION CONTINUES TO INCREASE AT A | $118,133 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $102,249 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $66,938 |
| 2026 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) -THE U.S. NATIONAL SCIENCE FOUNDATION (NSF) GRADUATE RESEARCH FELLOWSHIP PROGRAM (GRFP) IS A HIGHLY COMPETITIVE FEDE | $53,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF THE DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES IN VASCULAR DYSFUNCTION AND HYPERTENSION IN THE CONTEXT OF HIV - PROJECT SUMMARY COMBINATION ANTIRETROVIRAL TH | $44,267 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HDAC7-DRIVEN REPROGRAMMING OF PKM2 FUNCTION IN LUNG VASCULAR PERMEABILITY - PROJECT SUMMARY ACUTE LUNG INJURY (ALI) IS CHARACTERIZED BY BREAKDOWN OF THE PULMONA | $44,077 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | INVESTIGATING THE IN VIVO REGULATION OF DYNEIN ACTIVITY - THE ESTABLISHMENT AND MAINTENANCE OF POLARITY IS A FUNDAMENTAL FEATURE OF EUKARYOTIC CELLS. MOLECULAR | $42,545 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | RYAN WHITE HIV/AIDS PROGRAM DENTAL REIMBURSEMENT AND COMMUNITY BASED DENTAL PARTNERSHIP GRANTS 93.924 | DENTAL REIMBURSEMENT PROGRAM - APPLICATION ORGANIZATION: THE DENTAL COLLEGE OF GEORGIA (DCG) AT AUGUSTA UNIVERSITY (AU) ADDRESS: 1120 15TH STREET, AUGUSTA, GA 3 | $41,578 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $26,106 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $15,145 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $5,663 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $896 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HDAC9 NUCLEAR/CYTOPLASMIC SHUTTLING IN PULMONARY VASCULAR ENDOTHELIAL BARRIER REGULATION - PROJECT SUMMARY ACUTE LUNG INJURY (ALI) IS CHARACTERIZED BY LUNG VASC | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | EXPLOITING THE IMMUNOMODULATORY EFFECTS OF SULINDAC AND NOVEL NON-COX INHIBITORY DERIVATIVES FOR CANCER TREATMENT | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | 5HT3 RECEPTORS AND BLOOD-BRAIN BARRIER DYSFUNCTION IN ADRD - 5HT3 RECEPTORS AND BLOOD-BRAIN BARRIER DYSFUNCTION IN ADRD PROJECT SUMMARY/ABSTRACT THE EXACT CAUSE | $0 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | $0 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | SHORT-CHAIN FATTY ACID SIGNALING IN RETINOPATHY OF PREMATURITY - THE GOAL OF THE CURRENT APPLICATION IS TO IDENTIFY NOVEL MECHANISMS AND, DEVELOP A NEW AND EFFE | -$1 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MITOCHONDRIA DYNAMICS PROTEIN DRP1 IN ROS SIGNALING, ENDOTHELIAL METABOLISM AND ANGIOGENESIS - THE AIM OF THIS GRANT IS TO ELUCIDATE THE ROLE OF MITOCHONDRIAL D | -$1 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE METABOLOMIC CONSEQUENCES OF SMALL SIZE AND LONG LIFE - PROJECT SUMMARY THIS RESEARCH PROPOSAL HAS BEEN DEVELOPED TO EQUIP THE CANDIDATE, DR. JESSICA HOFFMAN | -$2 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MIR182 AND OCULAR HYPERTENSION. - ABSTRACT DESPITE THE SIGNIFICANT RESEARCH EFFORT OF MICRORNAS (MIRNAS) IN THE PATHOGENESIS OF GLAUCOMA, THEIR SPECIFIC ROLES | -$3 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SCISIPBIO: DISTINGUISHING PRACTICES OF OUTSTANDING PRODUCTIVITY AND EXPANSION IN BIOMEDICAL RESEARCH - CONSEQUENTIAL, REPRODUCIBLE SCIENTIFIC RESEARCH HAS LED T | -$3 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$7 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$30 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IDENTIFYING MECHANISMS AND TREATMENTS FOR COGNITIVE DECLINE FOLLOWING NEUROTOXIC ALPHA-SYNUCLEIN EXPOSURE IN NEW PARKINSONS DISEASE MODELS | -$78 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | THE ROLE OF CELLULAR SENESCENCE IN BONE LOSS AND RECOVERY IN PERIODONTAL DISEASE - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF TOOTH-SUPPORTING ALVEOLAR BONE LO | -$87 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | VASCULAR MACROPHAGES AND T CELLS IN ATHEROSCLEROSIS | -$116 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE REGULATION AND FUNCTION OF LONG NON CODING RNA IN ISCHEMIC AKI: ROLE OF GSTM3P1 - SUMMARY: ACUTE KIDNEY INJURY (AKI) IS A MAJOR RENAL DISEASE THAT CAN BE CA | -$137 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | DEVELOPING A PLATFORM FOR ENGINEERING CUSTOMIZABLE CELL-CELL SIGNALING IN VIVO - ABSTRACT. SYNTHETIC BIOLOGY COMBINES BIOLOGICAL AND ENGINEERING PRINCIPLES TO R | -$176 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$177 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | QUANTITATIVE PROTEOMIC ANALYSIS OF THE AGING BRAIN AFTER INTRACEREBRAL HEMORRHAGE - INTRACEREBRAL HEMORRHAGE (ICH) IS A DEVASTATING SUBTYPE OF STROKE WITH NO EF | -$197 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$236 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ROLE OF VAMP1 IN SYNAPTIC TRANSMISSION AND ALZHEIMER'S DEMENTIA | -$248 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MITOCHONDRIAL STRESS IN LIVER FUNCTION AND DYSFUNCTION - PROJECT SUMMARY THE LIVER IS RESPONSIBLE FOR THE MULTITUDE OF PROCESSES, NOTABLY THE METABOLIC HOMEOSTA | -$390 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$422 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | APPLICATION OF PULSED FOCUSED ULTRASOUND (PFUS) TO DELIVER ENGINEERED THERAPEUTIC EXOSOMES FOR THE TREATMENT OF ISCHEMIC STROKE - WE HAVE SHOWN ENHANCED DELIVER | -$683 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$865 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | REPURPOSING OF R-ETODOLAC FOR ALZHEIMER'S DISEASE AND RELATED DISORDERS - REPURPOSING OF R-ETODOLAC FOR ALZHEIMER’S DISEASE AND RELATED DISORDERS SUMMARY THE DE | -$927 |
| 2026 | Department of the Navy | Grant or other assistance | BASIC AND APPLIED SCIENTIFIC RESEARCH 12.300 | A SOCIO-POLITICAL ANALYSIS OF ARABIC SOCIAL MEDIA ATTACKS USING COMPUTATIONAL MODELING | -$1,003 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THORACIC NEUROMODULATION FOR DIABETIC GASTROPARESIS - PROJECT SUMMARY/ABSTRACT THE GLOBAL INCIDENCE OF DIABETES IS RISING. GASTROPARESIS IS A SIGNIFICANT COMPLI | -$1,213 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$1,300 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTION AND REGULATION OF TSPAN2 IN VASCULAR DISEASE | -$1,811 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | BETA AMYLOID-ADRENERGIC RECEPTOR INTERACTION IN ALZHEIMER'S DISEASE | -$2,110 |
| 2026 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | ANIMAL LAB & CORE SERVICES | -$2,562 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THERAPEUTIC TARGETING OF MONOACYLGLYCEROL LIPASE AFTER TRAUMATIC BRAIN INJURY | -$2,822 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NOVEL INSIGHTS ON IMMUNE THROMBOCYTOPENIA PURPURA WITH PLATELET CONTRACTION CYTOMETRY - PROJECT SUMMARY/ABSTRACT DEFINED BY A LOW PLATELET COUNT IN THE ABSENCE | -$4,278 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ROLE OF HISTONE DEACETYLASE 9 (HDAC9) IN ADIPOSE TISSUE AGING: MITOCHONDRIAL FUNCTION, OXIDATIVE STRESS AND SENESCENCE - PROJECT SUMMARY ADIPOSE TISSUE IS A MAJ | -$5,539 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MYELOID GLYCOLYSIS IN PATHOLOGICAL OCULAR ANGIOGENESIS | -$6,339 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PIK3C3, A MASTER REGULATOR FOR SMOOTH MUSCLE IDENTITY - PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS (VSMCS) FROM A CONTRACTILE TO A PROLIFERATIVE PHENO | -$9,827 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DECIPHERING THE MECHANISMS AND CELLULAR ROLES OF MONOMER-DRIVEN ACTIN DYNAMICS | -$10,451 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | INTERACTION OF GENETIC AND ENVIRONMENTAL FACTORS IN KERATOCONUS - ABSTRACT THE GOAL OF THIS PROJECT IS TO SHED LIGHT ON THE ETIOLOGY OF KERATOCONUS (KC) BY ELUC | -$18,913 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | NF2/MERLIN IN VASCULAR SMOOTH MUSCLE CELLS | -$19,909 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE ROLE OF ADENOSINE KINASE IN MIXED DIASTOLIC HEART FAILURE AND ALZHEIMER DISEASE - PROJECT SUMMARY ALZHEIMER’S DISEASE (AD) IS A PREVALENT DISEASE WITH LITTL | -$23,913 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS OF FOAMY MONOCYTE FORMATION IN ATHEROSCLEROSIS - PROJECT SUMMARY ATHEROSCLEROSIS, THE UNDERLYING CAUSE OF HEART ATTACK, STROKE AND PERIPHERAL ARTERIA | -$26,213 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | RURAL HEALTHCARE SERVICES PROGRAMS 93.912 | RURAL COMMUNITIES OPIOID RESPONSE-IMPLEMENTATION | -$27,480 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERPLAY OF SEX HORMONES AND CHROMOSOMES IN VASCULAR OXIDATIVE STRESS AND ARTERIAL STIFFENING - PROJECT SUMMARY SEX STEROIDS AND CHROMOSOMES BOTH CONTRIBUTE T | -$27,812 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MOLECULAR ORIGINS OF PHENOTYPIC CHANGES IN THE OBESE MICROVASCULAR ENDOTHELIUM - PROJECT SUMMARY OBESITY IS A MAJOR RISK FACTOR FOR CARDIOVASCULAR DISEASES (CVD | -$41,307 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | DEVELOPMENT OF MURINE GLIOBLASTOMA MODEL FOR ONCOLYTIC HSV THERAPY - THE OVERALL GOAL OF THIS PROJECT IS TO CREATE A MURINE-MODELS FOR GRADE IV BRAIN TUMORS THA | -$98,093 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | REMOTE ISCHEMIC CONDITIONING PROMOTES CEREBROVASCULAR RECOVERY AFTER INTRACEREBRAL HEMORRHAGE | -$105,396 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BIOPHYSICAL MECHANISMS OF HYPEROXIA-INDUCED LUNG INJURY | -$137,518 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | REGULATION OF SORLA BY BETA-ARRESTIN2 - THE ULTIMATE GOAL OF THIS STUDY IS TO ADVANCE OUR UNDERSTANDING OF THE COMPLEXITY OF ALZHEIMER’S DISEASE (AD) PATHOPHYSI | -$763,559 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE CELL INTERACTIONS IN ATHEROSCLEROSIS | $2,358,435 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ENDOTHELIAL METABOLISM AND REDOX IMBALANCE IN VASCULAR DISEASE - PROJECT SUMMARY REDOX IMBALANCE BETWEEN REACTIVE OXYGEN SPECIES (ROS) AND REACTIVE NITROGEN SPE | $2,264,097 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGE-INDUCED IMPAIRMENT OF NUTRIENT SIGNALING RESULTS IN BONE LOSS | $2,218,187 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | IMPROVING AWARENESS OF WOMEN WITH HYPERTENSION: ROAR (RURAL, OBESE, AT RISK) - MORE THAN 1 IN 3 WOMEN ARE LIVING WITH HEART DISEASE AND MANY ARE UNAWARE OF THE | $1,493,938 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CALCULATOR FOR LENGTH OF USE OF BISPHOSPHONATES (CLUB) - OSTEOPOROTIC FRACTURES ARE A MAJOR PUBLIC HEALTH PROBLEM, ESPECIALLY FOR OLDER PERSONS. BISPHOSPHONATES | $1,340,488 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CONTROL 93.399 | GEORGIA CARES | $1,264,038 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | COORDINATING UNIT FOR THE INNOVATIVE SCIENCE ACCELERATOR PROGRAM - THE GOAL OF THE NIDDK INNOVATIVE SCIENCE ACCELERATOR (ISAC) PROGRAM IS TO NOT ONLY PROVIDE FU | $1,249,999 |
| 2025 | Health Resources and Services Administration | Grant or other assistance | RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT 93.912 | RURAL COMMUNITIES OPIOID RESPONSE PROGRAM - MEDICATION ASSISTED TREATMENT ACCESS | $995,864 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | VASCULAR MACROPHAGES AND T CELLS IN ATHEROSCLEROSIS | $769,886 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | REPURPOSING OF R-ETODOLAC FOR ALZHEIMER'S DISEASE AND RELATED DISORDERS - REPURPOSING OF R-ETODOLAC FOR ALZHEIMER’S DISEASE AND RELATED DISORDERS SUMMARY THE DE | $769,189 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTION AND TRANSCRIPTIONAL REGULATION OF LEIOMODIN1 - PROJECT SUMMARY RECENT LINEAGE TRACING AND SINGLE CELL OMICS STUDIES PROVIDE IRREFUTABLE EVIDENCE FOR VA | $768,198 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SKELETAL MUSCLE HEALTH PROTECTS VASCULAR FUNCTION IN OBESITY - PROJECT SUMMARY OBESITY REMAINS THE MOST PERSISTENT THREAT TO CARDIOVASCULAR HEALTH IN THE UNITE | $766,920 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | POSTTRANSLATIONAL CONTROL OF VSMC IDENTITY AND VASCULAR HEALTH - THE PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS (VSMCS) FROM A CONTRACTILE TO A PROLIF | $766,667 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CU UPTAKE TRANSPORTER AS A DISTURBED FLOW SENSOR IN VASCULAR INFLAMMATORY DISEASE - PROJECT SUMMARY THE AIM OF THIS GRANT IS TO ELUCIDATE THE NOVEL ROLE OF ENDO | $762,300 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NOVEL MECHANISMS OF HIV-ASSOCIATED PULMONARY VASCULAR DISEASE - PROJECT SUMMARY THANKS TO THE ADVENT OF COMBINATION ANTIRETROVIRAL THERAPY (CART), LIFE EXPECTAN | $760,760 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ROLE OF BRAIN AROMATASE IN ALZHEIMER'S DEMENTIA: SEX DIFFERENCES AND THE PREVENTIVE THERAPY USING PULSED PHOTOBIOMODULATION - ABSTRACT ALZHEIMER'S DISEASE (AD) | $754,578 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PHASE I STUDY OF PANOBINOSTAT IN ADULTS WITH SICKLE CELL DISEASE: NOVEL APPROACH TO RECRUITMENT AND RETENTION - ABSTRACT ALTHOUGH AN ORPHAN DISEASE IN THE US WI | $750,712 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DARC, INFLAMMAGING AND ALZHEIMER'S DISEASE - PROJECT SUMMARY CHRONIC INFLAMMATION OF THE BRAIN OCCURS WITH AGING AND PLAYS AN IMPORTANT ROLE IN AGE-RELATED COGN | $741,989 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CALPAIN/TALIN/MLCP AXIS IN PULMONARY ENDOTHELIAL BARRIER REGULATION - PROJECT SUMMARY ACUTE LUNG INJURY (ALI) IS CHARACTERIZED BY LUNG VASCULAR ENDOTHELIAL CELL | $721,969 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GALECTIN-3: A MEDIATOR OF VASCULAR REMODELING IN PULMONARY ARTERIAL HYPERTENSION | $700,700 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MOLECULAR CONTROL OF VASCULAR SMOOTH MUSCLE REPROGRAMMING IN ARTERIOVENOUS FISTULA MATURATION - PROJECT SUMMARY A SURGICALLY CREATED ARTERIOVENOUS FISTULA (AVF) | $685,966 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | THE ROLE OF CHD7 IN ACC NEURONS - A LIMITED FUNDAMENTAL UNDERSTANDING OF THE CELLULAR AND MOLECULAR MECHANISMS UNDERLYING COMPLEX BEHAVIORS POSES A MAJOR BARRIE | $681,473 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | TARGETING THE CD73-ADENOSINERGIC PATHWAY IN HEAD AND NECK CANCER - HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSC) RELATED TO TOBACCO AND ALCOHOL CONSUMPTION IS AG | $677,163 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS OF HIV-ASSOCIATED HYPERTENSION - PROJECT SUMMARY OVER THE LAST FEW DECADES, THE ADVENT OF COMBINATION ANTIRETROVIRAL THERAPY HAS LED TO A PROFOUND SU | $669,900 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ROLE OF AGRP NEURONS IN CHRONIC STRESS-ACCELERATED BRAIN AGING AND PROGRESSION OF ALZHEIMER'S DISEASE - PROJECT SUMMARY CHRONIC STRESS IS INCREASINGLY BEING REC | $668,212 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ELUCIDATING THE ROLE OF CULLIN 3 IN THE HEART - PROJECT SUMMARY CARDIOMYOCYTE (CM) MITOCHONDRIA PLAY A CRUCIAL ROLE IN ENERGY PRODUCTION AND OTHER ESSENTIAL CEL | $667,414 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | VASCULAR SMOOTH MUSCLE PROTEIN QUALITY CONTROL AND AORTIC ANEURYSM FORMATION - PROJECT SUMMARY ABDOMINAL AORTIC ANEURYSM (AAA) IS A DEVASTATING DISEASE CARRYING | $665,628 |
| 2025 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | CYBERCORPS SCHOLARSHIPS FOR SERVICE: AUGUSTA UNIVERSITY DEVELOPING IMMERSIVE EXPERIENCES FOR NOVEL CYBERSECURITY EDUCATION | $648,632 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | GUT METABOLITES, T CELLS, AND SALT-SENSITIVE HYPERTENSION - SUMMARY HYPERTENSION IS A PRIMARY MODIFIABLE RISK FACTOR FOR CARDIOVASCULAR, CEREBROVASCULAR, AND RE | $629,859 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ASTROCYTIC OSMR/JAK/STAT SIGNALING IN AD - THE ROLE OF REACTIVE ASTROCYTES IN ALZHEIMER’S DISEASE (AD) PATHOGENESIS REMAINS LARGELY UNDERSTUDIED. LITTLE IS KNOW | $626,766 |
| 2025 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | NOVEL MECHANISMS OF MUSCLE AND BONE LOSS WITH HIV INFECTION, ANTIRETROVIRAL THERAPY, AND AGING. - OUR PROPOSAL IS IN DIRECT RESPONSE TO THE SPECIAL FUNDING OPPO | $621,147 |
Patents
77 US patents filed in the last 20 years; 1 security interest recorded against them.
- Augusta University Research Institute, Inc. 77 patents, 2016-06-21 to 2026-10-13 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12759992 | Compositions and methods for inhibiting IDO1 | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12740995 | Methods and compositions for treating neurodegenerative diseases | 2026-09-22 | PTBLXML, file of 2026-09-22 |
| US 12734179 | Progesterone formulation to trigger ovulation and provide luteal phase support | 2026-09-15 | PTBLXML, file of 2026-09-15 |
| US 12668777 | Chimeric antigen receptor T cells and methods of use thereof | 2026-06-30 | PTBLXML, file of 2026-06-30 |
| US 12662485 | Substituted pyrazolo[4,3-D]pyrimidines as gut-targeted phosphodiesterase inhibitors | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12649774 | CAR-T cell compositions, methods of use thereof | 2026-06-09 | PTBLXML, file of 2026-06-09 |
| US 12616690 | Specific AKT3 activator and uses thereof | 2026-05-05 | PTBLXML, file of 2026-05-05 |
| US 12465232 | Method and system for monitoring brain function and intracranial pressure | 2025-11-11 | PVGPATDIS, file of 2026-04-10 |
| US 12209127 | Antibodies to programmed cell death protein 1 | 2025-01-28 | PVGPATDIS, file of 2026-04-10 |
| US 12208270 | Methods and systems for deep brain stimulation of the nucleus basalis of Meynert | 2025-01-28 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
3 US trademarks, 0 live.
- Augusta University Research Institute, Inc. 3 marks, GA EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| NANOSHUNT | 87897498 | 2018-04-27 | Abandoned | TRCFECO2, file of 2024-03-27 |
| (design) | 87897087 | 2018-04-27 | Abandoned | TRCFECO2, file of 2024-03-27 |
| NANOSHUNT | 87114607 | 2016-07-25 | Abandoned | TRCFECO2, file of 2024-03-27 |
The newest marks of the trademark owners above, matched to this record by name (and state).
In the news
8 news articles name this organization (March 2017 to October 2023); the latest 8:
- NSF Pumps $10.9M into Safe AI Tech Development
miragenews.com, October 31, 2023 - HHS funds inject millions into Georgia's HIV battle
projectq.us, October 26, 2021 - KidneyCure announces 2021 grant recipients
7thspace.com, July 1, 2021 - KidneyCure announces 2021 grant recipients
eurekalert.org, July 1, 2021 - The American Cancer Society and Pfizer Launch Community Grants Focused on Addressing Systemic Race-Related Barriers that Contribute to Disparities in care Among Black Men and Women with Cancer
prnewswire.com, November 17, 2020 - Emergency Telehealth Network Working Together Amid COVID-19
usda.gov, August 5, 2020 - accesswdun.com
accesswdun.com, January 21, 2018 - 4-traders.com
4-traders.com, March 6, 2017
News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "augusta university research institute". A shared name is not proof of the same organization; how the matching works. Most in the news.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| College | Augusta University | GA | Colleges and universities (IPEDS) | matched by the colleges loader: research (EXACT) |
| Federal award recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC | AR | Federal spending (USAspending) | EIN (EXACT) |
| Lobbying client | AUGUSTA UNIVERSITY RESEARCH INSTITUTE | GA | Federal lobbying (LDA) | name and state |
| Payment recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Augusta University Research Institute,inc | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Augusta University Research Institute, Inc. | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC. | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC | GA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | AUGUSTA UNIVERSITY RESEARCH INSTITUTE INCORPORATED | GA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Augusta University Research Institute, Inc. | GA | Patents (USPTO) | name and state |
| Trademark owner | Augusta University Research Institute, Inc. | GA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
NTEE code Graduate, Professional Schools (Separate Entities), GA first:
- GRACE BIBLICAL SEMINARY INC GA
- BEREA BIBLE INSTITUTE AND SEMINARY INC GA
- REFORMED UNIVERSITY INC GA
- INTERNATIONAL SCHOOL OF THEOLOGY AND LEADERSHIP INC GA
- INSTITUTE FOR THE STUDY & GA
- PRESBYTERIAN GENERAL ASSEMBLY THEOLOGICAL SEMINARY PGATS INC GA
- GEORGIA ACADEMY COSMETIC DENTISTRY GA
- BLACKBERRY EDUCATOR EMPOWERMENT INI TIATIVE INC GA
- LIVING THE CHARGE INC GA
- NARRATIVE & IDENTITY TRANSFORMATION INSTITUTE GA
In other datasets, the same topic (Education) in GA:
- IPO registrant: Boxlight Corp (IPO registrations (S-1, F-1))
- Lobbying client: ADVANCED, INC. (Federal lobbying (LDA))
Interests: Graduate, Professional Schools (Separate Entities) · science:research_education · women:issues · Education
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Census Tract 110, Richmond County, Georgia, place (city or town) Augusta-Richmond County, GA, county Richmond County, GA, state Georgia; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).
- DR JORGE CORTES was paid $776,083, 14.0 times the median household income in Augusta-Richmond County, GA ($55,485), where 20.1% of residents live in poverty.
- Revenue of $105,936,769 is $526 per resident of Augusta-Richmond County, GA (population 201,528).
- That revenue equals 2.54% of all household income in Augusta-Richmond County, GA (75,222 households at the median $55,485, about $4,173,692,670).
| Measure | Census tract Census Tract 110, Richmond County, Georgia | Place (city or town) Augusta-Richmond County, GA | County Richmond County, GA | State Georgia |
|---|---|---|---|---|
| Population B01003 | 1,726 | 201,528 | 206,069 | 10,940,407 |
| Population, 2020 census P1 | 1,946 | 202,081 | 206,607 | 10,711,908 |
| Median age B01002 | 57.5 | 35.2 | 35.2 | 37.6 |
| Under 18 B01001 | 7.2% | 22.8% | 22.9% | 23.2% |
| 65 and over B01001 | 34.8% | 15.3% | 15.3% | 15.0% |
| Households B11001 | 1,206 | 75,222 | 76,694 | 4,074,366 |
| Foreign born B05002 | 8.1% | 3.8% | 3.8% | 11.2% |
| Median household income B19013 | $29,286 | $55,485 | $55,637 | $77,353 |
| Median family income B19113 | $91,818 | $67,013 | $67,063 | $93,754 |
| Per capita income B19301 | $40,182 | $31,910 | $31,825 | $40,924 |
| Poverty rate B17001 | 21.4% | 20.1% | 20.0% | 13.4% |
| Unemployment rate B23025 | 10.3% | 8.6% | 8.5% | 5.1% |
| Civilian labor force B23025 | 585 | 93,954 | 95,771 | 5,496,061 |
| Mean commute (minutes) B08013 | 20.7 | 21.1 | 21.4 | 28.3 |
| Bachelor's degree or higher B15003 | 33.4% | 24.7% | 24.5% | 34.9% |
| Housing units B25001 | 1,509 | 91,432 | 93,145 | 4,541,835 |
| Owner-occupied B25003 | 15.2% | 50.8% | 51.2% | 65.7% |
| Renters B25003 | 84.8% | 49.2% | 48.8% | 34.3% |
| Median home value B25077 | $331,800 | $178,400 | $178,500 | $303,300 |
| Median gross rent B25064 | $853 | $1,142 | $1,141 | $1,393 |
| White, not Hispanic B03002 | 54.2% | 30.9% | 31.4% | 49.1% |
| Black B03002 | 31.1% | 56.2% | 55.7% | 30.7% |
| Hispanic or Latino B03002 | 4.8% | 5.9% | 5.8% | 11.0% |
| Asian B03002 | 3.9% | 1.6% | 1.6% | 4.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 3.3% in Sep 2026 (3.4% a year earlier); per capita personal income $65,111 in 2025, up 26% in five years (+1.6% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 110, Richmond County, Georgia.
Comments